Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2021 Aug 9;17(8):e1009806. doi: 10.1371/journal.ppat.1009806

Loss of Septation Initiation Network (SIN) kinases blocks tissue invasion and unlocks echinocandin cidal activity against Aspergillus fumigatus

Ana Camila Oliveira Souza 1,#, Adela Martin-Vicente 1,#, Ashley V Nywening 2, Wenbo Ge 1, David J Lowes 1, Brian M Peters 1,3, Jarrod R Fortwendel 1,3,*
Editor: Robert A Cramer4
PMCID: PMC8376064  PMID: 34370772

Abstract

Although considered effective treatment for many yeast fungi, the therapeutic efficacy of the echinocandin class of antifungals for invasive aspergillosis (IA) is limited. Recent studies suggest intense kinase- and phosphatase-mediated echinocandin adaptation in A. fumigatus. To identify A. fumigatus protein kinases required for survival under echinocandin stress, we employed CRISPR/Cas9-mediated gene targeting to generate a protein kinase disruption mutant library in a wild type genetic background. Cell wall and echinocandin stress screening of the 118 disruption mutants comprising the library identified only five protein kinase disruption mutants displaying greater than 4-fold decreased echinocandin minimum effective concentrations (MEC) compared to the parental strain. Two of these mutated genes, the previously uncharacterized A. fumigatus sepL and sidB genes, were predicted to encode protein kinases functioning as core components of the Septation Initiation Network (SIN), a tripartite kinase cascade that is necessary for septation in fungi. As the A. fumigatus SIN is completely uncharacterized, we sought to explore these network components as effectors of echinocandin stress survival. Our data show that mutation of any single SIN kinase gene caused complete loss of hyphal septation and increased susceptibility to cell wall stress, as well as widespread hyphal damage and loss of viability in response to echinocandin stress. Strikingly, mutation of each SIN kinase gene also resulted in a profound loss of virulence characterized by lack of tissue invasive growth. Through the deletion of multiple novel regulators of hyphal septation, we show that the non-invasive growth phenotype is not SIN-kinase dependent, but likely due to hyphal septation deficiency. Finally, we also find that echinocandin therapy is highly effective at eliminating residual tissue burden in mice infected with an aseptate strain of A. fumigatus. Together, our findings suggest that inhibitors of septation could enhance echinocandin-mediated killing while simultaneously limiting the invasive potential of A. fumigatus hyphae.

Author summary

Aspergillus fumigatus is a ubiquitous fungal pathogen and the major causative agent of a life-threatening infection known as invasive aspergillosis (IA). IA is a disease in which, typically immune compromised, patients experience unfettered growth of this pathogenic mold in the lungs with dissemination to other organs being common. Therapeutic options are limited by multiple factors and only three major antifungal drug classes are currently in use. Although effective as treatment for other fungal diseases, the echinocandin class of antifungals have limited usefulness against IA. Our overall goal is to identify novel fungal proteins that, if targeted for inhibition as part of a co-therapeutic approach, could improve the anti-Aspergillus activity of echinocandins and therefore lead to better patient outcomes. Here, we sought to identify A. fumigatus genes required for fungal survival under echinocandin stress by generating and screening an A. fumigatus mutant library composed of disruptions in genes encoding putative protein kinases. We found that protein kinases required for hyphal septation are essential for survival in the presence of echinocandins and, surprisingly, for the ability of A. fumigatus to invade lung tissue. Our results suggest that novel septation inhibitors could enhance echinocandin activity while simultaneously limiting A. fumigatus virulence.

Introduction

Aspergillus fumigatus is among the most common causes of human invasive fungal infections in immunocompromised individuals, including solid organ transplant recipients, those undergoing hematopoietic stem cell transplant, and patients receiving highly immunosuppressive chemotherapies [13]. If untreated, these infections are almost always fatal and, even with proper diagnosis and treatment, are associated with an overall ~50% mortality rate [4]. Furthermore, the estimated annual cost of Aspergillus infections in the U.S. approaches $1 billion [5]. The most life-threatening Aspergillus infection occurs typically in the setting of profound and prolonged immune suppression and is known as invasive aspergillosis (IA). IA is initiated by the inhalation of A. fumigatus conidia from the environment [6]. In the immune compromised host, these conidia undergo a process of germination characterized by an initial phase of isotropic swelling followed by a switch to highly polarized growth leading to the formation of a germ tube. These germ tubes continue to extend through focused growth at the cell apex to generate the invasive hyphal forms that can invade surrounding tissue in search of nutrients, eventually reaching the pulmonary microvasculature system to disseminate [6]. Although decades of research have focused on A. fumigatus conidial adherence to and nutrient utilization in the host lung environment, as well as on the cellular and molecular processes essential for subsequent hyphal formation and invasion, our understanding of these processes remain incomplete.

Therapy of invasive aspergillosis is limited to three currently available classes of antifungal compounds. The polyene class, of which Amphotericin B is the only member used for invasive disease, can be associated with acute infusion-related toxicities as well as nephrotoxicity with prolonged administration [7]. The triazole class are the frontline treatment for Aspergillus infections, with voriconazole considered the treatment of choice for this indication [8]. Treatment of aspergilloses is often prolonged, and mold-active antifungal prophylaxis employing triazole drugs is now common [913], both of which increase the potential for the development of drug-resistant organisms. Since the 1990s, triazole resistance in clinical isolates of this fungal pathogen has been increasing worldwide and is now the subject of significant research in the US and abroad [1420]. Therefore, clinical use of the polyene and triazole classes is limited by patient toxicity and threatened by resistance, respectively.

The third major class of antifungals with anti-Aspergillus activity are the echinocandins, including caspofungin, micafungin and anidulafungin. These compounds are generally well-tolerated and are often used in salvage therapy for invasive infections [21]. Echinocandins are specific inhibitors of cell wall biosynthesis in fungi, as they inhibit the activity of the β-1,3-glucan synthase enzyme. This enzyme is encoded by the fksA gene in A. fumigatus and is the sole protein driving synthesis of the major cell wall component, β-1,3-glucan [22]. Whereas the activity of the echinocandins is fungicidal for the major yeast pathogens of the Candida genus, they are considered fungistatic against the Aspergilli [21,23]. Treatment of A. fumigatus with echinocandins causes lysis of hyphal tips and blunting of hyphal growth, but viability is maintained [24]. In addition, a caspofungin paradoxical effect (CPE) of growth inhibition has been described for caspofungin both in vitro and in vivo and is characterized by decreasing effectiveness of drug with increasing concentrations [21,25]. Current research suggests that the CPE is the result of the induction of tolerance mechanisms within hyphal compartments that survive caspofungin therapy. These mechanisms include remodeling of the cell wall, upregulation of cell wall integrity machinery and the induction of calcium-regulated stress pathways [21,25]. Although not conclusive, multiple studies using models of invasive aspergillosis have suggested that the CPE is not merely an in vitro phenomenon and may be an issue underlying treatment failure during caspofungin therapy of invasive aspergillosis in specific cases [25]. Likely underpinned by the fungistatic nature of the echinocandins against Aspergilli, breakthrough infections during echinocandin prophylaxis have been reported to be as high as 28% [26] and one study has identified echinocandin prophylaxis as an independent risk factor for breakthrough infections when compared with triazole prophylaxis [27]. Therefore, the echinocandins are mostly utilized where triazole therapy is contraindicated or has failed for invasive aspergillosis.

Recent studies have shown that the phospho-proteome of Aspergilli is highly responsive to echinocandin-induced stress, implying extensive kinase- and phosphatase-mediated re-wiring of cellular physiology for survival during inhibition of β-1,3-glucan biosynthesis [2830]. Further, multiple studies in A. fumigatus have implicated protein kinase and protein phosphatase activity as important to cell wall stress imposed by echinocandins [3136]. Together, these reports suggest that the further study of phospho-regulatory events required for survival during echinocandin-induced stress could uncover novel avenues for combination therapies directed at enhancing echinocandin activity against Aspergilli and other human pathogenic fungi. Here, we utilized a CRISPR/Cas9-based rapid gene disruption technique to generate a protein kinase gene disruption library in a wild type genetic background of A. fumigatus. Screening of this library for cell wall stress and echinocandin sensitivity phenotypes uncovered multiple protein kinases contributing to growth under each condition. In addition to the previously characterized cell wall integrity pathway and cAMP-mediated signaling protein kinases, our screens identified orthologs of the Septation Initiation Network (SIN) kinases as essential for growth under echinocandin-induced stress [37,38].

As septa are considered essential for the limitation of cell wall damage to filamentous fungal hyphae and the putative SIN is unstudied in A. fumigatus, we sought to further characterize the importance of each A. fumigatus SIN kinase to survival under echinocandin-induced stress both in vitro and during invasive disease. Our data indicate that each SIN kinase is essential for septum formation and for survival under echinocandin-induced cell wall stress. Strikingly, each of the SIN kinase disruption mutants were avirulent in a corticosteroid model of invasive aspergillosis (IA) and two of the three mutants were also avirulent in a chemotherapeutic model of IA. This lack of virulence was characterized by loss of tissue invasion and inability to accumulate fungal burden. Nevertheless, using culture-based residual fungal tissue burden as a gold-standard determination of fungicidal activity, we show that echinocandin therapy was enhanced in mice infected with SIN kinase mutants. Further, we show that loss of additional regulators of septation also results in avirulence characterized by lack of tissue invasion and loss of viability under echinocandin stress, suggesting that our phenotypes are likely due to loss of septation and not septation-independent functions of the A. fumigatus SIN.

Results

Generation of an A. fumigatus protein kinase disruption mutant library

To identify protein kinase-driven pathways important for survival under echinocandin stress in A. fumigatus, we first generated a protein kinase disruption library in the A1163 (CEA10) wild type genetic background through coupling of CRISPR/Cas9-based gene targeting with a miniaturized protoplast transformation technique. Putative protein kinase genes were first identified through BLAST searches of the A. fumigatus A1163 (CEA10) genome database at FungiDB (fungidb.org) using the previously published known protein kinases of Aspergillus nidulans [39]. This search yielded 148 putative protein kinases representing 10 different protein kinase classes, as well as putative kinases falling into no known kinase class (S1 File). Of these 148 putative kinase genes, 142 were found to be encoded in the genomes of both sequenced laboratory strains, A1163 (CEA10) and Af293, and were therefore selected for disruption (S1 File). For library construction, we employed a miniaturized version of a CRISPR/Cas9-based gene editing technique, previously adapted in our lab, that provides up to 90% gene targeting efficiency in A. fumigatus [40,41]. Protospacer adjacent motif (PAM) sites for Cas9-induced double strand breaks and integration of hygromycin repair templates were selected using the Eukaryotic Pathogen CRISPR Guide RNA/DNA Design Tool (EuPaGDT, grna.ctegd.uga.edu) through batch upload analysis of all protein kinase coding sequences. Each PAM site was selected to direct double-strand DNA breaks near the putative transcriptional start site of each gene and integration of repair templates designed to disrupt readthrough of the first exon, when possible (S1 File). Cas9-ribonucleotides (RNPs) for gene targeting were assembled in vitro using custom designed guide RNAs (gRNAs) and commercially available Cas9 enzyme, as previously described [40]. Transformations were miniaturized into single wells of 96-well plates with a final well volume of 200 μl (Fig 1A). After transformation, total contents of individual wells were plated to osmotically stabilized agar and overlayed with hygromycin-containing top agar for selection (Fig 1B). Individual transformants were isolated to secondary selection plates and subsequently screened by multiple PCR reactions to confirm correct integration of the hygromycin repair template (Fig 1C). After three rounds of transformations, successful disruption of 118 protein kinase genes were confirmed (S1 File). The remaining 24 protein kinases for which disruptions were not achieved are largely orthologs of putatively essential genes in A. nidulans, suggesting conserved essentiality in A. fumigatus [39].

Fig 1. Construction of a protein kinase disruption library in A. fumigatus by CRISPR/Cas9-mediated gene editing.

Fig 1

A) Miniaturized protoplast transformations were carried out in 96-well plates, with a final total volume of 200 μl per well, and each well representing an attempted disruption of a single protein kinase gene. B) After the transformation process, the entire contents of each well were spread onto individual sorbitol minimal medium (SMM) agar plates and allowed to recover overnight at room temperature before overlaying with hygromycin-containing top agar for selection. Following these transformation procedures, typically 10 to 30 transformant colonies were evident on each selection plate after 3 to 4 days of incubation at 37°C. However, due to the high efficiency of gene targeting with the CRISPR/Cas9 system, only 3 to 4 colonies per transformation were required to be isolated for genotypic screening. C) Putative transformants were subjected to genotypic analyses by PCR to confirm proper integration of the repair template for gene disruption. These PCR analyses included screens with allele specific primer sets PF/PR and PF/IPR, pictured above. PF = Forward screening primer. PR = Reverse screening primer. IPR = Internal reverse screening primer complementary to HygR sequence. HygR = Hygromycin Resistance cassette, utilized as the repair template for gene disruption. All kinase genes were targeted for disruption at the 5’ end of the gene (within the first exon, where possible), as indicated by the placement of the protospacer and protospacer adjacent motif (PAM, red bold font) above.

Protein kinase-mediated regulation of A. fumigatus growth and asexual development

Of the 118 disrupted protein kinase mutant strains generated in this study, twenty-six were unable to grow at the same rate as the parental strain when cultured on standard laboratory minimal media. Disruption of seven different protein kinases resulted in a reduction of growth of greater than 50% when compared to the parent strain, generating compact colonies that were unable to expand radially on minimal media (Figs 2A and S1A). Among these kinase disruptions were the cell wall integrity mitogen-activated protein kinase (MAPK), mpkA (AFUB_070630), and the upstream MAPK kinase (MAPKK), mkkA (AFUB_006190). Loss of either of these kinases has been previously shown to result in compact colony morphology [35]. Although deletion of the cell wall integrity MAPKK kinase (MAPKKK), bck1 (AFUB_038060), was previously shown to result in reduced growth as well, disruption of this kinase in our library was associated with only a mild reduction in colony growth (Figs 2B and S1A). In addition, significantly reduced growth was generated by disruption of the catalytic subunit of Protein Kinase A, pkaC1 (AFUB_027890), or the PAK-kinase, cla4 (AFUB_053440) (Figs 2A and S1A). Both kinases were also previously characterized as important for vegetative growth in A. fumigatus [42,43]. Previously uncharacterized A. fumigatus protein kinases causing > 50% growth reduction upon disruption included orthologs of the eukaryotic LAMMER kinase (lkh1; AFUB_016170), an S. cerevisiae kinase regulating the actin cytoskeleton (prk1; AFUB_006320), and a cyclin-dependent protein kinase (sgv1; AFUB_053070) (Figs 2A and S1A). Eighteen additional protein kinase disruptions resulted in mild-to-moderate growth reductions ranging between 10–50% of the parental strain (Figs 2B and S1A). Of the previously characterized kinase genes fitting into this category, we identified slow growth in disrupted orthologs of a phosphorelay sensor kinase (tscB; AFUB_017740) [44], the Cross-Pathway Control kinase (cpcC; AFUB_054310) [45], a p21-Activated Kinase (PAK) family protein (ste20/pakA; AFUB_021710) [32], a cyclin-dependent protein kinase (ssn3; AFUB_035220) [46], and the cell wall integrity MAP kinase kinase kinase (bck1; AFUB_038060) [35] (Figs 2B and S1A). Thirteen mutant strains also displayed a significant impairment in asexual differentiation, as evidenced by significantly reduced conidia production, with nine of these kinase disruptions resulting in severe loss of conidiation when compared to CEA10 (Figs 2C and S1B). Six of these kinases have been previously characterized as required for conidiation, including three that comprise an asexual developmental kinase cascade in A. fumigatus (steC: AFUB_053960), ste7/mkkB; AFUB_043130, and mpkB; AFUB_078810) [47]. The remaining previously characterized kinases were pkaC1, mpkA, and cla4, each of which negatively impact asexual development upon deletion [35,42,43]. The finding that disruption of previously characterized growth-mediating kinases resulted in growth retardation of strains in our library supported the validity of our gene disruption approach. Therefore, these initial studies identified multiple novel protein kinases regulating A. fumigatus growth and development.

Fig 2. Colony morphologies of selected A. fumigatus protein kinase disruption mutants.

Fig 2

96-hr colony morphologies of severely (A) and moderately (B) growth restricted protein kinase disruption mutants, as well as colony morphologies of mutants that are not growth restricted but display reduced conidiation (C). Ten thousand conidia from each strain were point inoculated onto the center of minimal media agar and cultured for 96 hrs at 37°C.

Multiple protein kinases are required for growth under cell wall and echinocandin stress

To identify protein kinases required for cell wall stress tolerance, we performed spot-dilution assays in the presence of the common cell wall stress agents calcofluor white (CFW) and congo red (CR) on minimal media (MM), as well as caspofungin minimum effective concentration (MEC) assays, for all 118 viable kinase disruption mutants. Whereas caspofungin is an echinocandin-class antifungal that directly inhibits the fungal β-glucan synthase, CFW and CR are known to interfere with cell wall assembly by interacting with nascent chitin chains to prevent crosslinking of chitin to glucan moieties [48]. Spot-dilution assays identified seven protein kinase disruptions that displayed increased susceptibility to both CFW and CR, and an additional seven mutants that were hypersusceptible to only CR (Fig 3A and 3B). Among those 14 mutants found to be hypersusceptible to either cell wall active compound were the disruptions of the cell wall integrity kinases mkkA and mpkA (Fig 2A) which have previously been shown to be required for survival under various forms of cell wall stress [35]. Interestingly, the MAPKKK at the head of the A. fumigatus cell wall integrity pathway, Bck1, was again not identified by our assays as producing a cell wall stress hypersensitivity phenotype upon disruption. This finding, coupled with the lack of a severe growth restriction phenotype in Fig 2 for the bck1 disruption mutant, indicated that some mutations in our library may be either non-disruptive or only partially disruptive to gene function. Our cell wall stress screens also uncovered protein kinases whose disruption generated resistance to either CFW (pkaC1) or to CR (kfsA, cmkA, and stk22), as evidenced by the increased ability to sustain colony formation under stress (Fig 2C).

Fig 3. Multiple protein kinases contribute to cell wall integrity in A. fumigatus.

Fig 3

A) Protein kinase gene disruption mutants displaying increased susceptibility to both cell wall disrupting agents, calcofluor white (CFW) and congo red (CR), by spot-dilution assay when compared to the wild type parent (CEA10). B) Protein kinase gene disruption mutants displaying hyper-susceptibility to only CR when compared to the parent strain. C) Protein kinase gene disruptants displaying increased resistance to CFW (pkaC1-1) or to varying concentrations of CR (kfsA-1, cmkA-1, and stk22-1). For each target protein kinase gene, the systematic name is listed with the strain name given in parentheses. Strain names were designed using either the previously published or putative (based on homology to Aspergillus nidulans) gene names with the addition of “-1” to indicate a disruption mutation of that gene. GMM = glucose minimal media with no CFW or CR added. For all assays, conidial inocula were applied at 104, 103, 102, and 101 total conidia and plates were incubated at 37°C for 72 hrs.

To see if the CFW and CR susceptibility phenotypes correlated with echinocandin susceptibility, modified caspofungin MEC analyses were performed by broth microdilution (BMD) [49]. Whereas only five protein kinase disruption mutants were identified to display ≥ 4-fold increased susceptibility to caspofungin (i.e., at least two dilution shift), an additional 44 mutants displayed a 2-fold (one dilution) increase in caspofungin susceptibility (S1 File). Of those mutants that we previously identified as hypersusceptible to CFW, CR, or both, only the AFUB_087120, AFUB_013090 (cak1), and AFUB_018600 (pom1) disruption mutants showed no shift in caspofungin MEC values. All other cell wall stress susceptible mutants displayed at least a 2-fold reduction in caspofungin MEC values (S1 File). Interestingly, the disruption mutants for AFUB_09320 (cmkA), AFUB_014350 (kfsA), and AFUB_027890 (pkaC1) which displayed increased resistance to either CFW or CR, also displayed increased susceptibility to caspofungin (2-fold reduced MEC). Importantly, among the caspofungin hypersusceptible kinase mutants that displayed ≥ 4-fold decreased MEC values were those known to be involved in cell wall integrity signaling (mpkA and mkk2) and the cAMP-activated protein kinase (pkaC1), of which mpkA and pkaC1 have been previously characterized as necessary for response to echinocandin stress [50,51].

Mutation of two additional kinases that are not members of the cell wall integrity pathway, AFUB_095460 (sidB) and AFUB_05070 (sepL), also displayed high levels of susceptibility in both of our cell wall stress and caspofungin MEC assays (Fig 3A and S1 File). These putative A. fumigatus kinases are orthologous to the A. nidulans SepL and SidB kinases that function as members of the Septation Initiation Network (SIN) kinase cascade. The core of the A. nidulans SIN pathway is composed of three kinases: the SteK-class proteins, SepH and SepL, and the AGC-class kinase, SidB (Fig 4A) [39]. Deletion of any single A. nidulans SIN kinase gene results in aseptate hyphae and reduction of conidiation whereas analysis of the Neurospora crassa SIN kinase orthologs has found only two of the three conserved kinases to be essential for the process of hyphal septation [39,52]. As the SIN pathway is completely uncharacterized in A. fumigatus, we sought to examine the importance of each SIN kinase to hyphal septation and to protection against echinocandin damage both in vitro and in vivo during invasive aspergillosis.

Fig 4. The Septation Initiation Network (SIN) kinases are each required for hyphal septation and protection against cell wall damage in A. fumigatus.

Fig 4

A) The putative core SIN pathway in A. fumigatus based on signal transduction models constructed for Schizosaccharomyces pombe and Aspergillus nidulans. A protein kinase cascade, initiated by activation of the SepH kinase through interaction with the GTP-bound GTPase, Spg1, leads to downstream activation of the SepL and SidB kinases to eventually promote initiation of septation. SepL and SidB are shown with their putative regulatory binding partners, SepM and Mob1, respectively. B) Deletion of sepHsepH) phenocopies sepL and sidB disruption (sepL-1 and sidB-1, respectively) as evidenced by restricted colony size and loss of conidiation (i.e., white colony formation). Complementation of SIN activity in the sepL-1 disruption mutant by gene replacement (sepL-1-C’) results in full growth recovery and conidiation. Ten thousand conidia from each strain were spot-inoculated onto the center of a GMM agar plate and cultured for 96 hrs at 37°C. C) Loss of any single SIN kinase results in absence of growth in the presence of the cell wall destabilizing compounds CFW or CR. Conidia from each strain were spot inoculated in descending concentrations onto GMM alone or GMM containing either 40 μg/ml CFW or CR. D) Loss of any single SIN kinase results in the absence of septa in mature hyphae. Conidia from each strain were cultured to mature hyphae (16 hrs at 37°C) and subsequently stained with calcofluor white (CFW) and propidium iodide (PI) to visualize septa and nuclei, respectively. White arrowheads indicate septa in the CEA10 (parent) and sepL-1 complemented (sepL-1-C’) strains. No septa were evident in the ΔsepH, sepL-1 or sidB-1 mutants.

A. fumigatus SIN kinases are required for septation and for survival in response to echinocandins

Although a disruption of the sepH gene was generated as part of our initial library construction, the sepH-1 mutant did not show the same colony growth, conidiation, cell wall stress or echinocandin stress phenotypes as the sepL-1 or sidB-1 mutants. To see if our sepH-1 mutant actually represented a loss of gene function, we also generated a complete gene deletion of sepH by CRISPR/Cas9 gene targeting (S2A and S2B Fig) and found that this mutant (ΔsepH) phenocopied the other SIN kinase disruption mutants with respect to colony phenotype and cell wall stress imposed by CFW and CR (Fig 4B and 4C). This finding indicated that, as for the bck1-1 mutant, disruption of sepH using our approach likely only partially impacted function. For that reason, the ΔsepH deletion mutant and not the sepH-1 disruption mutant was used moving forward. Inspection of mature hyphae from each mutant using CFW fluorescence staining to highlight the cell wall revealed that septation was completely ablated upon loss of any single SIN kinase (Fig 4D). Nuclear morphology and positioning in the each of SIN kinase mutants was grossly normal (Fig 4D), indicating that septation is not required for this aspect of A. fumigatus hyphal biology. This finding is in line with data reported for other septate filamentous fungi in which the cell cycle and cytokinesis (i.e., septation) are linked but not essentially coupled, as in yeast organisms [53]. Repair of SIN kinase pathway activity through complementation of the sepL-1 disruption by re-integration of the sepL wild type allele into the native locus (S2C and S2D Fig) resulted in complete recovery of all growth and cell wall stress phenotypes (Fig 4B and 4C). In addition, this sepL-1 complement strain (sepL-1-C’) displayed a complete recovery of septum formation (Fig 4D).

We next performed both E-test and fluorescence-based quantitative killing assays comparing the CEA10 parent and each SIN kinase mutant. E-test assays were performed utilizing both caspofungin (CAS) and micafungin (MFG) embedded strips and the production of a zone-of-clearance recorded after 48 hours of culture. In keeping with the fact that echinocandins are fungistatic against Aspergilli, the CEA10 parental strain displayed no zone-of-clearance surrounding E-test strips from either echinocandin (Fig 5A and 5B). Only an elliptical zone of depressed growth was evident for CEA10 and agar cores taken from within this zone grew normally when supplanted to agar containing no echinocandin (Fig 5A and 5B, inset). In contrast, each of the SIN kinase mutants developed a visible zone-of-clearance for both echinocandins suggesting significantly inhibited growth (Fig 5A and 5B). The only exception to this was found on the ΔsepH E-test plates for both echinocandins where a small number of compact microcolonies were able to form in the zone-of-clearance (Fig 5A and 5B, ΔsepH panels). Agar cores removed from the zone-of-clearance from each SIN kinase mutant plate were inviable when supplanted to drug-free agar. When specifically selected for sub-culture to drug-free agar, the ΔsepH zone-of-clearance microcolonies generated viable colonies but maintained hypersensitivity to both echinocandins on retest. These findings implied that the zone-of-clearance generated on the SIN kinase mutant E-test plates represented fungicidal activity of both echinocandins. In contrast, E-test and broth microdilution assays revealed no differences in voriconazole antifungal drug susceptibility among the SIN kinase mutants when compared to the parental strain (MIC = 0.5 μg/ml for all strains).

Fig 5. The A. fumigatus SIN kinases are required for survival under echinocandin stress.

Fig 5

A, B) Loss of sepH, sepL, or sidB increases susceptibility to echinocandins in a modified E-test assay. 1 x 106 total conidia in 500 μl sterile water from the wild type parent (CEA10), the sepH deletion (ΔsepH), or the sepL (sepL-1) or sidB (sidB-1) disruption strains were spread evenly over GMM agar plates. E-test strips for caspofungin (A) or micafungin (B) were applied and assays incubated for 48 hrs. Note the zone-of-clearance with no detectable growth for the ΔsepH, sepL-1 and sidB-1 mutants in the presence of either echinocandin. Insets show representative, drug-free minimal media culture plates onto which a single agar plug from the zone-of-clearance for each assay was sub-cultured. Multiple agar plugs (n = 10), taken from within 1 cm of the E-test strip and between the 32 and 0.25 ug/ml markers, were sub-cultured in the same manner for each assay. Note lack of growth for the SIN kinase mutant subcultures. CAS = caspofungin, MFG = micafungin. C) Quantitation of viability by CFDA staining of the CEA10 control and SIN kinase mutants in the absence of echinocandin stress. Conidia from each strain were germinated for 12 hrs and subsequently stained with 5-carboxyfluorescein diacetate (CFDA) to detect live hyphal elements. D) Quantitation of viability by CFDA staining of the strain set in the presence of caspofungin. Conidia from each strain were cultured for 12 hrs and 24 hrs at 37°C in the presence of 0.5 μg/ml caspofungin and subsequently stained with CFDA to detect live microcolonies. CFDA positivity was scored for 100 microcolonies in each experiment and all assays were completed in triplicate. Data were averaged for each strain and treatment. One-way ANOVA and Dunnett’s multiple comparisons post hoc analyses indicated differences in CFDA staining in the absence of micafungin were not significant (n.s.), whereas the ΔsepH, sepL-1 and sidB-1 mutants were significantly less viable after 12 and 24 hrs growth in the presence of caspofungin. ****p<0.0001; ***p = 0.0001. E) Echinocandin stress during early growth stages leads to death of the SIN kinase mutants. White arrowhead denotes example of a microcolony stained positive with CFDA (bright green). Black arrowhead denotes a CFDA-negative microcolony. Dash-lined arrows denote dead (CFDA-negative) hyphal compartments of CFDA-positive microcolonies only seen in the CEA10 control.

To more quantitatively measure SIN kinase mutant death in response to echinocandin stress, we also employed fluorescence-based assays using the live-cell stain 5-carboxyfluorescein diacetate (CFDA). CFDA is a cell-permeable esterase substrate that has been previously used as a viability indicator for A. fumigatus and other fungi [23]. Conidia from the parent strain and each SIN kinase mutant were grown in the presence or absence of 0.5 μg/ml micafungin and subsequently stained with CFDA to detect germlings and / or microcolonies with live hyphae or hyphal segments. Using fluorescence microscopy, individual microcolonies from each strain were scored as either live (CFDA-positive) or dead (CFDA-negative). In the absence of micafungin, the CEA10 parent and SIN kinase mutants displayed similar levels of CFDA-positive staining after 12 hours of culture, indicating similar baseline viability among the strain set (Fig 5C). Quantitation of CFDA-positivity past the 12-hour timepoint was not possible in the untreated samples, as continued hyphal growth obscured individual microcolonies for all strains. After 12 hours of growth in the presence of micafungin, each of the SIN kinase mutants displayed significant reductions in CFDA positivity, showing between only 40% and 60% positivity (Fig 5D). The CEA10 parent maintained an almost 90% positivity in staining. At the 12-hour timepoint, germlings in the CEA10 parent were noted to be either fully CFDA-positive (Fig 5E, white arrowhead) or to display unstained hyphal tip regions with positively stained subapical segments (Fig 5E, black dotted line arrows). In contrast, each of the SIN kinase mutants displayed either wholly CFDA-stained or -unstained (Fig 5E, black arrowhead) germlings. These findings suggested protection of interseptal hyphal segments of the CEA10 parent that was lost in the SIN kinase mutants due to lack of septation. Further, after 24 hours of culture in the presence of micafungin, the SIN kinase mutants displayed no CFDA positivity, whereas the CEA10 parent maintained almost 100% positive staining (Fig 5D).

Both the E-test and CFDA-based killing assays described above measured the impacts of echinocandin stress when applied to each strain from the onset of growth (i.e., before conidial germination begins). As septa were completely lacking in mature hyphae of each of the SIN kinase mutants, we also reasoned that damage from mature hyphal tip lysis induced by echinocandins would no longer be confined to the tip compartment, as previously described [24,54]. To test this, conidia from the parental and each mutant strain were cultured to mature hyphal growth before addition of micafungin (0.5 μg/ml) and hyphal damage was subsequently analyzed by propidium iodide (PI) permeability [55]. In the absence of echinocandin-induced stress, hyphae from each strain showed little-to-no permeability to PI, supporting the CFDA staining results and suggesting that loss of SIN pathway function alone does not significantly impact cell wall integrity (Fig 6A). In contrast, hyphal damage induced by 2 hours of micafungin treatment of the SIN kinase mutants was extensive and widespread when compared to the wild type parental control (Fig 6B). This was evidenced by increased uptake of PI in each SIN kinase mutant after micafungin exposure, highlighting full hyphal elements (Fig 6B). In contrast, the CEA10 parent strain stained only minimally with PI after micafungin exposure and staining was largely restricted to specific hyphal segments (Fig 6B, inset white arrowheads). Together, these results suggested that SIN kinase activity is required for septation which, in turn, is required for limiting hyphal damage in the presence of echinocandin antifungals. Removing this barrier appeared to result in cidal anti-Aspergillus activity against each of the SIN kinase mutants.

Fig 6. Hyphae of SIN kinase mutants exhibit extensive damage in the presence of echinocandin.

Fig 6

Analysis of hyphal integrity using propidium iodide (PI) permeability as a measure of damage in response to echinocandin stress. Mature hyphae from the CEA10, ΔsepH, sepL-1, and sidB-1 strains were stained with PI (12.5 μg/ml) before (A) or after 2 hours (B) exposure to micafungin (0.5 μg/ml). Upper panels are brightfield images and lower panels are fluorescence acquired. Hyphae from all strains exhibited minimal staining with no exposure to echinocandin, suggesting intact cell walls (A). Limited staining of hyphal compartments was noted in the CEA10 parental strain after 2 hrs micafungin exposure, suggesting cell wall damage limited by the presence of septa (B, lower panel inset, white arrowheads denote hyphal compartment). In contrast, extensive PI staining was induced after micafungin treatment in each of the SIN kinase mutant strains (B). All fluorescence images were acquired at using identical exposure. Scale bar = 100 μm.

A. fumigatus SIN kinases are required for tissue invasive growth

To examine the impacts of hyphal septation loss on virulence, we next compared the CEA10 parent and SIN kinase mutant strains in two well-described mouse models of invasive aspergillosis, representing chemotherapeutic and corticosteroid-induced immune suppression [56]. Mice (n = 8 / arm) were immune suppressed with injections of cyclophosphamide and triamcinolone acetonide or with triamcinolone acetonide alone for the chemotherapeutic and corticosteroid model, respectively. For both models, mice were intranasally inoculated with 1 x 105 conidia and survival was followed for 15 days post-inoculation. Sham treated mice (n = 5 / arm), receiving only intranasal sterile saline inoculations coupled with immune suppressive regimens, resulted in no mortality. For the CEA10 parent strain, mortality began at Day +4 in both models with 100% mortality reached by Day +7 in the chemotherapeutic model and mortality reaching 60% by Day +15 in the corticosteroid model (Fig 7A and 7B). As a measure of virulence in a strain where SIN kinase pathway activity was restored after disruption, the sepL-1-C’ complement strain induced mortality statistically similar to that of the CEA10 parent in both models (Fig 7A and 7B). Surprisingly, the SIN kinase mutants were avirulent in both models, with the only exception being the sepL-1 mutant which induced 50% mortality only in the chemotherapeutic model (Fig 7A and 7B). All SIN kinase mutant-induced mortality levels were significantly reduced, compared to the parent strain. To examine the histopathological impact of hyphal septation loss on infection, we also analyzed hyphal growth in vivo through silver-stained tissue sections of infected lungs from each group. At 4 days post-infection, the wild type CEA10 strain had generated large, deeply invasive hyphae (Fig 8). In contrast, each of the SIN kinase mutants had formed small hyphal masses residing only in the open airways at the same timepoint post-infection (Fig 8). No deeply invasive growth was noted for any SIN kinase mutant. A single instance of shallow invasion was noted for the ΔsepH mutant and this was associated with what appeared to be a loss-of-polarity phenotype characterized by highly branched hyphal tips (Fig 8, inset). These data suggested that the SIN kinase pathway is essential to virulence through support of invasive tissue growth.

Fig 7. SIN kinase activity is required for virulence in mouse models of invasive aspergillosis.

Fig 7

Mice (n = 8 / group for ΔsepH, sepL-1, sidB-1 and sepL-1-C’; n = 16 for CEA10) were chemotherapeutically immune suppressed with both cyclophosphamide and triamcinolone acetonide (A) or triamcinolone acetonide alone (B) and inoculated with 1 x 105 conidia of the indicated strain. Survival was followed for 15 days post-inoculation. Statistical analyses (Mantel-Cox Log-rank test) identified significantly reduced virulence for all SIN kinase mutant strains vs. the CEA10 control.

Fig 8. Loss of virulence among the SIN kinase mutants is associated with lack of tissue invasion.

Fig 8

Low- and high-magnification photomicrographs of Gomori methenamine silver (GMS)-stained lung tissue sections from the CEA10, ΔsepH, sepL-1 and sidB-1 at day +4 post-inoculation. Mice were immune suppressed with triamcinolone acetonide and inoculated with each strain as described for the previous survival studies. Hyphae (black stained fungal elements) from the CEA10 strain were noted to invade lung tissue, forming fulminant lesions. In contrast, growth of each SIN kinase mutant was limited to the airways with minimal to no tissue invasion (white arrowheads). Rare tissue invasion was associated with loss of polarity maintenance (ΔsepH inset panel). Scale bar = 50 μm.

To quantitatively analyze SIN kinase mutant fitness and host-pathogen interaction, we next completed qPCR-based fungal burden assays, as previously described [57]. Mice (n = 5 / group) were immune suppressed following the chemotherapeutic protocol and subsequently infected with 1 x 106 conidia from each strain by intranasal inoculation. At Day +4, lungs were aseptically removed and processed for genomic DNA extraction. qPCR-based quantitation of A. fumigatus DNA in lung tissues revealed that both the ΔsepH and sidB-1 mutants accumulated significantly less fungal burden in vivo than the CEA10 parent (Fig 9A). Although the sepL-1 mutant displayed reduced burden by qPCR when compared to CEA10, this difference was not statistically significant (Fig 9A). This inability to accumulate wild type levels of fungal mass in vivo was also associated with a diminished ability to induce pro-inflammatory cytokine release in vivo. ELISA-based detection of IL-1β and TNFα in lung homogenates from the same mice utilized for fungal burden revealed that all SIN kinase mutants induced significantly lower cytokine levels compared to the CEA10 control (Fig 9B and 9C). To test if these findings were simply due to negative impacts on fitness, we compared the abilities of the SIN kinase mutants to induce IL-1β release in vitro using the THP-1 macrophage-like cell line. Release of IL-1β is a pro-inflammatory response typically induced by A. fumigatus cell wall PAMP exposure and is known to be dependent on inflammasome signaling [58,59]. Differentiated THP-1 cells were co-incubated with conidia from the wild type CEA10 or SIN kinase mutants (MOI 10:1) for 16 h and supernatants were subsequently analyzed for IL-1β release by ELISA. Surprisingly, all SIN kinase mutants were found to induce significantly lower levels of IL-1β release when compared to CEA10 (Fig 9D). In addition, IL-1β release in our assay was confirmed to be dependent on activation of the NLRP3 inflammasome, as the CEA10 parental strain was unable to induce IL-1β release in NLRP3-/- or ASC-/- cells, components necessary for canonical inflammasome activation and assembly (Fig 9E) [60]. Inflammasome-dependence was further evidenced by the ability to block Aspergillus-induced IL-1β release using the well-characterized NLRP3 inhibitor, MCC950 (Fig 9F). Together, these data indicate that the SIN kinase pathway is not only important for supporting A. fumigatus pathogenic fitness but is also required for normal damage-induced immune activation.

Fig 9. Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection.

Fig 9

A) Analysis of fungal burden by qPCR at day +4 post inoculation. Mice (n = 5 / group) were immune suppressed with cyclophosphamide and triamcinolone acetonide and inoculated with 1x 106 conidia from each strain. Data are represented as nanograms of A. fumigatus specific DNA in 500 ng of total DNA. * p < 0.02. Quantitation of IL-1β (B) and TNFα (C) revealed decreased host response in SIN kinase mutant infected mice. Mice (n = 5 / group) were immune suppressed as indicated for fungal burden analysis and lung tissue was removed at day +4 post-inoculation, homogenized and analyzed by ELISA. **p = 0.0024 for (B); **p = 0.0031 for (C). An in vitro IL-1β release assay uncovered decreased induction of inflammasome activation by the SIN kinase mutants. D) Conidia from each strain were co-incubated with phorbol 12-myristate 13-acetate (PMA)-activated THP-1 cells (MOI 10:1) for 16 hrs and supernatants analyzed by ELISA for IL-1β concentration. ***p < 0.0001; **p = 0.0014. E) Inflammasome dependence of IL-1β release was established by co-culturing PMA-activated WT (THP1-null), Nlrp3−/− (THP1-KO-NLRP3), and Asc−/− (THP1-KO-ASC) THP-1 cells with CEA10 conidia (MOI 10:1) as indicated for (D). ***p < 0.0001. F) Inflammasome dependence of Aspergillus-induced IL-1β release was further confirmed by repeating this assay in the presence of the inflammasome inhibitor, MCC950 (10 μM). ***p < 0.0001. All experiments were conducted in technical replicates (n = 4) and repeated independently in triplicate. Statistical comparisons in (A), (B), (C), and (D) were made by one-way ANOVA with Dunnett’s multiple comparisons test post hoc and represent comparison of each SIN kinase mutant to the CEA10 control. Statistical comparisons in (E) were made by one-way ANOVA with Dunnett’s multiple comparisons post hoc and represent the NLRP3-/- and ASC-/- versus WT control. The statistical comparison of MCC950 versus vehicle in (F) was made by unpaired T-test.

Loss of hyphal septation improves echinocandin-mediated fungal clearance during invasive disease

Taken together, our in vitro and in vivo data suggest that A. fumigatus mutants lacking septa should be more susceptible to echinocandin therapy during infection. To examine the in vivo therapeutic relevance of our in vitro findings, we next employed the wild type CEA10 parent and the sepL-1 strain in a chemotherapeutic mouse model of invasive aspergillosis with and without echinocandin therapy. The sepL-1 mutant and chemotherapeutic model were chosen here as this combination was found to result in measurable mortality in our previous experiments. Ten mice per experimental arm were infected with 106 conidia of either the CEA10 or sepL-1 strain by intranasal inoculation on day 0. On Days +1, +2 and +3, mice were administered (or not) micafungin therapy (1 mg/kg/day or 2 mg/kg/day) by intraperitoneal injection (three total doses). Survival at the end of the 14-day infection was 0% for the CEA10 untreated arm and 75% for the sepL-1 untreated arm (p = 0.002) (Fig 9A). Strikingly, with micafungin therapy at 2 mg/kg/day, the sepL-1 mutant-infected mice exhibited 100% survival whereas the wild type strain-infected mice, treated in the same manner, produced 0% survival by day +9 (p < 0.0001) (Fig 9A). Although survival differences between treated and untreated CEA10 and sepL-1 strains were significant for each therapeutic regimen, we found no significant difference between sepL-1 treated and untreated experimental arms (Fig 10A). This was due to a combination of the low virulence of the sepL-1 mutant and the number of mice used per arm. However, in a separate experiment, the ability of micafungin therapy to enhance the reduction of residual tissue burden in sepL-1 infected mice was also examined. Mice (n = 8 / arm) were immune suppressed and inoculated identical to survival assays and were provided (or not) micafungin therapy at days +1, 2, and 3. Lungs were removed at day +0 or day +4, sectioned, and cultured on Inhibitory Mold Agar at 37°C for 48 hours. All non-micafungin treated mice infected with either the CEA10 or sepL-1 strains produced positive fungal cultures using tissue extracted at day +0 and day +4, indicating live fungus in the lung environment for both strains at this timepoint (Fig 10B). At day +4 with micafungin therapy (2 mg/kg/day), 75% of CEA10-infected mouse lung cultures (6 / 8) were still positive for fungal growth (Fig 10B). Compared to fungal colony morphologies arising from micafungin-free lungs (CEA10 day +0 or day +4, no micafungin), the micafungin-treated mouse lung cultures produced compact colony growth confirming presence of micafungin in tissues during therapy (Fig 10B). In contrast, lungs from sepL-1 infected, micafungin-treated mice extracted at day +4 contained no culturable fungal elements (Fig 10B). Together, these data suggest that loss of hyphal septation improves echinocandin therapy by enhancing the ability of this drug class to clear invading A. fumigatus hyphae from the lung.

Fig 10. Loss of hyphal septation improves echinocandin therapy characterized by clearance of fungal burden from lung tissue.

Fig 10

A) Survival analysis of mice infected with either the CEA10 or sepL-1 mutant strain with and without micafungin therapy. All mice were immune suppressed through intraperitoneal injection of cyclophosphamide on days -3, +1, +4, and +7 and a single subcutaneous injection of triamcinolone acetonide on day -1. Mice were inoculated with 1 X 106 conidia of the indicated strain suspended in 20 μl of sterile saline on day 0 and then received three separate intraperitoneal injections of micafungin at either 1 mg/kg (MFG1) or 2 mg/kg (MFG2) on days +1, +2 and +3. Statistical comparisons were made by Mantel-Cox log-rank test and represent each sepL-1 mutant experimental arm compared to its CEA10 control (i.e., CEA10 saline vs. sepL-1 saline, CEA10 MFG1 vs. sepL-1 MFG1, and CEA10 MFG2 vs. sepL-1 MFG2). B) CEA10 and sepL-1 residual lung tissue burden at day 0 and day 4 with and without micafungin 2 mg/kg therapy. Organ cultures are shown from two representative animals from each treatment group. Note that the sepL-1 infected mice treated with micafungin 2 mg/kg are culture negative at day 4 post-inoculation. MFG = micafungin.

Gene deletion of additional septation mediators phenocopies the SIN kinase mutants

As the striking loss of virulence and tissue invasion phenotypes of the SIN kinase mutants could be dependent or independent of hyphal septation, we next wanted to test whether these phenotypes could be replicated in a SIN kinase-independent but septation-dependent manner. Therefore, we sought to identify novel genes essential for septation in A. fumigatus. In the model filamentous fungus, A. nidulans, the acnA gene encodes an alpha-actinin protein that is essential for hyphal septation and loss of septation in a strain lacking acnA is associated with a complete absence of contractile actin ring assembly [61]. This data mirrors results reported for a Schizosaccharomyces pombe alpha-actinin gene, ain1, which is also mediates CAR assembly in the model fission yeast [62]. Additionally, in Saccharomyces cerevisiae, the MLC1 gene encodes for a myosin light chain protein that is essential for regulating myosin heavy chain interactions during contractile actin ring assembly [63]. Loss of S. cerevisiae MLC1, or the mlc1 ortholog in S. pombe (cdc4), results in lethality for both yeasts due to the inability to complete CAR formation and subsequent cytokinesis [64,65]. Given their conserved roles in septation and the non-essential nature of septation in A. fumigatus, we reasoned that we should be able to acquire gene deletions of the A. fumigatus orthologs of acnA and MLC1 for further study here. The putative protein sequences for acnA and MLC1 from A. nidulans and S. cerevisiae, respectively, were utilized for a BLASTp search of the A. fumigatus genome (FungiDB). For MLC1, this search identified two proteins with significant identity to the Mlc1p sequence. These were proteins encoded by the uncharacterized gene, AFUB_091530 (42% identity), and an ortholog of the highly conserved calmodulin gene, AFUB_067160 (34% identity). Therefore, AFUB_091530 was chosen as the A. fumigatus MLC1 ortholog and named mlcA. Surprisingly, no orthologs of the A. nidulans AcnA protein could be identified in A. fumigatus. However, additional BLASTp searches using the S. pombe Ain1 protein sequence identified a single A. fumigatus gene, AFUB_055850, with 49% identity to Ain1 and was therefore named ainA. This BLASTp search also identified a single Ain1 ortholog in A. nidulans (AN7707) that was unique from the aforementioned AcnA protein. Employing CRISPR/Cas9-based gene targeting, single gene deletion and complementation mutants were generated for both genes (S3 Fig).

As was observed for the SIN kinase mutants, CFW staining of mature hyphae revealed loss of septum formation in the ΔmlcA and ΔainA mutants. Whereas the parental wild type CEA10 displayed fully formed septa after 20 hours of culture in minimal media, the ΔmlcA and ΔainA mutants formed completely aseptate hyphae. The ΔmlcA mutant was additionally characterized by the presence of brightly stained CFW-positive puncta of cell wall material throughout hyphae (Fig 11A). This finding suggests that, in addition to loss of septum formation, ΔmlcA deletion causes abnormal deposition of cell wall material during hyphal growth. E-test assays, employing anidulafungin-embedded strips, resulted in the formation of a zone-of-clearance for both the ΔmlcA and ΔainA mutants (Fig 11B). These results were similar to those generated by the SIN kinase mutants (Fig 5A and 5B). These findings were, again, in contrast to the wild type CEA10 parent that formed only a zone of depressed growth in response to echinocandin stress by E-test (Fig 11B). When employed for survival analyses in a corticosteroid model of invasive aspergillosis, ΔmlcA and ΔainA again phenocopied the SIN kinase mutants. At 15 days post-inoculation, both mutants resulted in no mortality whereas the wild type and complement strains performed similarly and produced significantly higher mortality (Fig 12A and 12C). Further, histopathological analysis of silver-stained tissue sections from lungs of mlcA and ainA infected mice revealed growth of fungal elements only in the airways (Fig 11B and 11D). These results again mirrored those for the SIN kinase mutants where a lack of tissue invasion was noted for aseptate hyphae (Fig 8). Together, these findings suggest that deletion or disruption of the signaling pathways or machinery required for septum initiation and formation results in the inability to support invasive growth in the host lung environment.

Fig 11. The A. fumigatus genes encoding myosin light chain (mlcA) and alpha-actinin (ainA) are required for hyphal septation and echinocandin resistance.

Fig 11

A) Characterization of septation by CFW staining of the wild type parental strain (CEA10) and the mlcAmlcA) and ainAainA) deletion mutants. Conidia from each strain were cultured to mature mycelial growth on sterile coverslips submerged in minimal media. Microscopic analysis of CFW-stained cultures revealed fully formed, normal septa in the CEA10 control strain (black arrow), whereas ΔmlcA formed aseptate hyphae with brightly stained puncta of cell wall material and ΔainA developed only aseptate hyphae. B) Anidulafungin E-test assays for each strain. Note the zone-of-clearance of the ΔmlcA and ΔainA strains which show the complete absence of growth.

Fig 12. Loss of septation caused by deletion of mlcA or ainA results in avirulence associated with lack of tissue invasion.

Fig 12

Survival analysis and GMS-stained tissue histology from immune suppressed mice infected with the ΔmlcA isogenic strain set (A) and (B) or the ΔainA isogenic strain set (C) and (D), respectively. Mice (n = 8 / strain) were immune suppressed with a single, subcutaneous injection of triamcinolone acetonide (40 mg/kg) on Day -1. On Day 0, all mice were intranasally administered 100,000 conidia suspended in 20 μl of sterile saline. No deaths were recorded in sham treated mice (sterile saline alone, n = 8). Statistical comparisons were made by Mantel-Cox log-rank test. Black arrows denote non-invasive fungal growth identified only in the airways of ΔmlcA and ΔainA infected mice.

Discussion

Hyphal septa are the product of incomplete cytokinesis and have long been appreciated to function as a protective barrier to mechanical and chemical stresses that disrupt the cell walls of filamentous fungi. This was the first investigation of the function of the SIN kinases in the human pathogen, A. fumigatus. The SIN complex has been studied most intensely in the fission yeast, Schizosaccharomyces pombe [66]. Although the SIN-complex shares similarity and encompasses some protein components homologous to those comprising the Mitotic Exit Network (MEN) in other yeast species like Saccharomyces cerevisiae, the signaling pathways are distinct [37,38]. The core of the SIN in S. pombe is composed of a GTPase protein, Spg1, that is negatively regulated by a two-component GTPase activating protein, Cdc16/Byr4 [37]. Although biochemical evidence is lacking even in the model organisms, this module is thought to signal through a kinase cascade consisting of the Cdc7 –Sid1 –Sid2 protein kinases with the co-regulatory components, Cdc14 and Mob1, binding to and regulating the Sid1 and Sid2 kinases, respectively [37]. The core tripartite kinase cascade is conserved in the model filamentous fungi A. nidulans (SepH-SepL-SidB) and Neurospora crassa (CDC-7, SID-1, DBF-2) [39,40] and the orthologs of these kinases were the focus of this study in A. fumigatus. Although downstream SIN-complex effectors are not verified in A. fumigatus, the Rho-type GTPase, Rho4, and the putative Rho Guanine Exchange Factors, Bud3 and Rgf3, are known to regulate septum formation and a rho4 deletion is the only mutation in A. fumigatus previously reported to completely block septation [52,54,67]. Rho4 has been proposed to be a downstream effector of SIN-kinase activity that, in turn, recruits a formin protein (SepA ortholog in A. fumigatus) to mediate assembly of the contractile actomyosin ring (CAR) on which the septum is built in A. nidulans [68]. The CAR is further built and constriction regulated by bundling of actin filaments through the action of α-actinin cross-linking proteins and by interactions with myosin light and heavy chain proteins [69]. Interestingly, although the A. nidulans α-actinin, AcnA, has been shown to regulate septation, we found this gene to not be conserved in A. fumigatus. This finding suggests differences in how A. fumigatus and A. nidulans regulate septum formation. In contrast, we found that the α-actinin gene, ainA, as well as the myosin light chain gene, mlcA, were conserved among A. fumigatus, A. nidulans and S. pombe. Both genes played essential roles in completion of septation. This event is intimately coupled with the exit from mitosis in S. pombe such that SIN-complex mutants are typically inviable in this yeast. In filamentous organisms like the Aspergilli, however, mitosis and septation are not interdependent and, as our data show, aseptate Aspergillus mutants are viable under normal growth conditions.

The initial publications describing anti-Aspergillus echinocandin activity as being characterized by fungal hyphal tip lysis, were also the first to suggest the possibility that hyphal septation likely underpins the fungistatic nature of this drug class against Aspergilli [24]. This conclusion was further supported by subsequently published genetic and pharmacologic evidence. For example, when the echinocandin-target gene fksA is deleted in A. fumigatus, hyphae are devoid of β-1,3-glucan and appear to be killed in the presence of compounds that inhibit septation [54]. Additionally, the aseptate Δrho4 A. fumigatus mutant cannot grow in the presence of echinocandins [52]. Although highly suggestive of an essential role for hyphal septation in protection against echinocandins, the septation inhibitors previously employed, hydroxyurea and diepoxyoctane, potentially have many off-target effects as developmental and cell cycle inhibitors and the rho4 gene was additionally characterized as directly contributing to modulation of the cell wall [52]. Our data definitively show that loss of A. fumigatus hyphal septation imparts fungicidal activity to echinocandins. Thus, septation is a mechanism to limit damage imposed by loss of cell wall integrity via inhibition of β-1,3-glucan synthesis. When faced with echinocandin stress, the FksA enzyme mislocalizes from its normal position at the hyphal tip and the tip compartment is lysed [70]. However, the interseptal compartments remain viable [24,70]. In many septation-competent fungi, septal pores that remain after septum formation to promote exchange of cytoplasmic materials plug quickly after cell wall damage to protect against cytoplasmic leakage [71,72]. After tip-lysis by echinocandins, new hyphal growth within the lysed hyphal tip compartments, known as “intrahyphal hyphae”, can develop from existing septa in the proximal subapical compartment [70]. The FksA enzyme is relocalized to these new sites of apical growth to support the nascent growth axis. Therefore, the septum may act not only as physical barrier to limit hyphal damage to the colony periphery, but also as a scaffold for continued hyphal growth under cell wall stress in the Aspergilli.

Under the conditions we tested, the aseptate SIN kinase mutants were more susceptible to echinocandin-mediated cell wall damage than even the CWI kinase mutants, which represent the core signaling pathway of cell wall stress responses (S4 Fig). The majority of published works identifying cellular mechanisms supporting A. fumigatus survival in response to echinocandins have logically focused on adaptive cell wall stress signaling, such as the CWI kinase cascade and cAMP-dependent protein kinase A signaling [21,32,34]. Although they represent potentially powerful targets for future combination therapies with echinocandins, inhibiting many of these pathways leaves the cell septation machinery largely intact and, therefore, provides the pathogen a means for persistence in the host under echinocandin stress. Recent studies suggest that the process of septation may also be stress responsive in fungi. In the yeast pathogen Candida albicans, loss of the CHS1 chitin synthase gene is lethal due to the central role of the Chs1p enzyme in building the primary septum for successful cell division [73]. However, induction of cell wall stress in a CHS1 repressed strain causes stress-induced formation of an alternative “salvage septum” by other chitin synthase enzymes, leading to completion of cytokinesis and cell survival in the absence of CHS1 [74]. Therefore, the enzymes that are typically required for the physical construction of the septum can be re-wired under cell wall stress to promote survival in C. albicans. In A. nidulans, a recent phosphoproteomics analysis of micafungin-stressed hyphae identified the SIN network ortholog, SidB, as being hyperphosphorylated in a manner likely dependent on the CWI MAPK, MpkA [30]. Further in vitro growth analyses analyzing septum formation in micafungin-stressed and micafungin-free samples revealed that the rate of septation increases during echinocandin-induced cell wall stress [30]. Together, these data argue that formation of this important protective barrier in filamentous fungi may be both a fundamental structural cellular component and stress responsive.

A plethora of previous studies have shown that neutrophil activity is required for clearance of hyphae and hyphal fragments during infection [75]. Patients most at-risk for invasive aspergillosis are profoundly neutropenic and, as such, viable hyphal fragments remaining after unsuccessful therapy or under sub-therapeutic levels of drug are potentially especially problematic. Our in vivo virulence data suggests that blockade of septation could negatively impact A. fumigatus persistence by promoting echinocandin-induced hyphal death, likely before effective adaptive responses can be upregulated. The nearly complete lack of virulence of the SIN kinase mutant strain was a surprising finding and is the first description of a connection between hyphal septation and virulence in a filamentous human pathogen. The molecular and cellular mechanisms for why septation is required for A. fumigatus virulence are unknown. However, loss of hyphal septation has been shown to block virulence of the smut fungus, Ustilago maydis, due to loss of needed turgor pressure to build the appressorium [76]. Although human infectious fungi do not utilize special infection structures like appressoria for invasion, the inability of A. fumigatus aseptate hyphae to invade murine lung tissue could be from lack of turgor pressure in the tip compartment required for physical invasion. A recent study exploring the connections between hyphal growth and polarity maintenance has found filamentous fungal organisms with fast growing hyphal tips and high turgor pressure to often lose polarity when undergoing invasive growth (i.e., penetration into small spaces) [77]. in contrast, slow growing fungi with lower turgor pressure are able to maintain a single polarized growth axes under the same conditions. Therefore, a trade-off exists between growth rate and morphological plasticity for these fungi that is especially important during invasive growth into substrates. As we noted loss of polarity in our SIN kinase mutants during attempted tissue invasive growth (Fig 8), it may be possible that septation is involved in imposing such a trade-off between growth rate, turgor pressure and maintenance of hyphal morphogenesis for A. fumigatus. Although we utilize multiple septation-deficient mutants in our study, our data do not strictly rule out the possibility that hypersusceptibility of the SIN kinase mutants to cell wall stress could be at least partially septum-independent. For example, the hyphal septation machinery may be required to maintain cell wall stability or may crosstalk with cell wall biosynthesis pathways for support of overall hyphal structure during tissue invasive growth. This explanation would suggest a regulatory link between septation and cell wall integrity / biosynthesis networks. In support of this possibility, our finding that the SIN kinase mutants displayed reduced stimulation of IL-1β release in vitro may argue that cell wall PAMP exposure and / or cell wall structure are impacted by loss of septation. Further in-depth studies on SIN kinase signaling and cell wall integrity pathways will fully delineate the septation-dependent and -independent mechanisms underpinning the tissue invasion phenotypes resorted here.

In conclusion, we report for the first time that hyphal septation in A. fumigatus is required for virulence of this important human pathogen. We also show, definitively, that loss of hyphal septation generates cidal activity of echinocandins against A. fumigatus and enhances in vivo echinocandin activity by promoting clearance of viable residual tissue burden. Together, our findings suggest that inhibitors of septation could enhance echinocandin-mediated killing while simultaneously limiting the invasive potential of A. fumigatus hyphae.

Materials and methods

Ethics statement

All experiments involving animals were approved by the Institutional Animal Care and Use Committee at the University of Tennessee Health Science Center under protocol number 19–0067.

A. fumigatus strains and growth conditions

The wild type strain, CEA10, was utilized as the parental strain for all genetic manipulations described herein. All strains generated as part of this study are listed in S1 File. For quantification of colony diameter, five microliters of sterile water containing 104 conidia were inoculated onto the center of glucose minimal media (GMM) agar plates [78] and incubated at 37°C. Colony diameters were measured every 24 hours and pictures were taken after 96 hours incubation. Colony diameters of each mutant were compared to those of the parental strain, CEA10, using two-way ANOVA with Tukey’s test for multiple comparisons (GraphPad Prism v8.2.1). To evaluate and quantify the production of conidia, 2x104 conidia of each mutant were inoculated onto the center of GMM agar plates and incubated for 4 days at 37°C. After this time, colony diameters were measured and conidia were harvested in identical volumes of sterile water from each plate. Recovered conidia were counted using a hemocytometer and results were expressed as conidia per mm2 of colony area. Results from the kinase disruption mutants were compared to CEA10 using one-way ANOVA followed by Dunnett’s test for multiple comparisons (GraphPad v8.2.1). Conidial quantification and colony diameters were determined at least twice for each mutant.

Genetic manipulations of Aspergillus fumigatus

All putative protein kinase encoding genes were identified via BLAST search of the A. fumigatus genome database (FungiDB.org) using the known protein kinases of Aspergillus nidulans [39]. In total, 142 putative protein kinase encoding genes were identified and are listed in S1 File. Each putative protein kinase gene was targeted for disruption in a wild type genetic background (CEA10) using a CRISPR-Cas9 gene editing technique previously described by our laboratory [41]. To increase throughput of mutant generation, standard A. fumigatus protoplast-mediated transformation protocols were adapted to a miniaturized, 96-well plate system.

Briefly, CRISPR RNAs (crRNAs) and primers used to amplify hygromycin resistance cassette repair templates, engineered to incorporate 40 bp micro-homology regions at both 5’ and 3’ ends, were designed using the Eukaryotic Pathogen CRISPR guide RNA/DNA Design Tool (EuPaGDT) from the University of Georgia (http://grna.ctegd.uga.edu/). This tool allows users to identify Protospacer Adjacent Motifs (PAM) sites and protospacers in desired regions of the genome while predicting off-target sites. Protospacer regions were selected within the first exon of each gene, when possible. Repair templates were designed to delete 5 nucleotides of the Open Reading Frame (ORF) upon integration in an attempt to generate a frameshift and, consequently, disrupt gene function in the event of read-through during transcription. Forward and reverse primers for generation of repair templates were purchased in arrayed 96-well plates and utilized for PCR reactions also carried out in 96-well plates. Five microliters of each PCR reaction was utilized for gel electrophoresis to ensure a single band of appropriate size was generated for each reaction. After confirmation of successful PCR, five microliters of the unpurified PCR reaction, containing about 200 ng of amplified repair template, was utilized for transformation. All primers utilized for repair template generation are listed in S1 File.

Guide RNAs (gRNAs) and Ribonucleoprotein (RNP) complexes for each gene were built in vitro using commercially available tracrRNA and Cas9 enzyme, as previously described [41]. To reduce the cost of each transformation, as well as the time required for library construction, we adapted a traditional A. fumigatus protoplast transformation procedure to a miniaturized system, which allowed the performance of each gene disruption in a final total volume of 200 μl. The transformations were carried out in 96-well plates (Fig 1), which allowed 96 different transformations in a single day. Briefly, 96-well plates with each well containing a transformation mixture composed of protoplasts (1–5 x 105), Cas9 RNP complex (1.2 μM gRNA + 500 ng Cas9), repair template (~200 ng), 60% polyethylene glycol 3350 (PEG 3350), and 11 μl of STC Buffer [79] were incubated on ice for 50 min. After this time, 57 μl of 60% PEG were added to each well and incubated at RT for 20 min. Finally, the volume of each well was brought to 200 μl using STC buffer and the entire contents of each well were plated onto a single Sorbitol Minimal Medium [79] agar plate. The protoplasts were allowed to recover by incubating the culture plates at RT overnight, and top agar (SMM with 0.75% agar) containing 450 μg / ml of hygromycin was added the next day. The plates were then incubated at 37°C until colonies were observed. After 3–4 days, single colonies were transferred to new GMM plates supplemented with 150 μg / ml of hygromycin, single spored and genotypically screened by multiple PCRs, as seen in Fig 1D.

To generate sepH, mlcA, and ainA deletion strains, CRISPR/Cas9-mediated gene targeting was employed, as previously described [41]. To aid in complete gene deletion, two PAM sites, located upstream and downstream of the respective genes, were selected and HygR repair templates were designed to contain microhomology regions targeting areas outside each PAM. Transformation was carried out as described above and positive transformants were screened by PCR. Complementation of the ΔsepH, ΔmlcA, ΔainA, and sepL-1 mutants was also carried out by CRISPR/Cas9-mediated gene targeting. The complete ORF for each gene was amplified from CEA10 genomic DNA to contain regions homologous to the target sequence (5’ end) as well as to a phleomycin resistance cassette (3’ end). The phleomycin resistance cassette was amplified from the plasmid pAGRP [80] and primers deigned to incorporate sequence complimentary to the 3’ end of the sepL locus. As such, an overlapping region between the two fragments was generated. New PAM sites outside of the targeted loci were selected for Cas9 RNP-targeting and both repair template fragments were mixed during transformation. Positive transformant colonies were confirmed for proper integration as described above.

Cell wall stress and echinocandin susceptibility assays

Protein kinase disruption mutants were screened for cell wall sensitivity by monitoring their growth in the presence of cell wall disrupting agents. Qualitative primary screens were performed with at least two biological replicates of each mutant and the parental strain by arraying strains (5 μl of a 104 conidia / ml suspension) onto GMM agar plates containing either 40 μg / ml or 80 μg / ml of either congo red (CR) or calcofluor white (CFW). To select positive hits from the primary screen, colony development was examined after incubation at 37°C for 72 hours and strains displaying decreased or increased colony size versus the parental isolate were chose for secondary analysis. GMM agar plates without CR or CFW were used as a growth control. For secondary analyses of strains selected from primary screens, quantitative spot dilution assays were conducted. In brief, fresh conidial suspensions were prepared from single spore isolates of each mutant and 5 μl of 10-fold serial dilutions ranging from 106 to 103 conidia / ml were inoculated onto GMM agar plates supplemented with 40 μg / ml or 80 μg / ml of either CR or CFW. Plates were again incubated at 37°C for 72 hours and GMM agar plates containing no compounds were used for growth control.

The in vitro activity of caspofungin was determined using a broth microdilution assay [50]. Briefly, ten two-fold dilutions of caspofungin, ranging from 4 to 0.0075 μg / ml, were prepared in RPMI and placed in round bottomed 96-well plates. Then, each well was inoculated with 2x104 conidia and incubated at 35°C. Caspofungin minimal effective concentration (MEC) was read after 24 hours, with the aid of an inverted mirror. The strain Candida krusei ATCC 6258 was used as a quality control to ensure accurate activity of the tested drug. The assays were repeated at least twice for each mutant. For those mutants showing reduced or increased susceptibility by at least one two-fold dilution in comparison to the parental strain, the antifungal activity was also evaluated by a spot dilution assay. Briefly, GMM agar plates containing 0.06–0.5 μg / ml of caspofungin, were inoculated with serial dilutions of conidia suspensions ranging from 104 to 10 conidia. The plates were incubated at 37°C for 72 hours and the growth of each mutant was recorded every 24 hours and compared to CEA10.

Antifungal susceptibility was also assessed using concentration gradient strips (Etest), using modification of a previously described protocol [81]. A suspension containing 106 conidia in 0.5 ml was homogeneously inoculated onto GMM agar plates. Caspofungin (CAS, Biomerieux) or micafungin (MFG, Biomerieux) embedded strips were applied onto the agar and plates were incubated at 37°C. The production of a zone-of-clearance was recorded after 48 hours of culture.

CFW and propidium iodide (PI) staining

CFW and PI staining were performed as previously described [82]. Briefly, one thousand conidia were cultured in coverslips submerged in liquid GMM. After 16 hours at 37°C, the coverslips with adherent hyphae were washed with 50 mM morpholinepropanesulfonic acid (MOPS) buffer solution, adjusted to pH 6.7 and then submerged in fixative solution (8% formaldehyde, 25mM EGTA, 5mM MgSO4, 5% DMSO and 0.2% Triton) for one hour at room temperature (RT). Coverslips were again washed twice with 50 mM PIPES for 10 min and treated with 100 μg / ml of RNAase A for one hour at 37°C. All samples were then washed twice with MOPS buffer and stained with 12.5 μg / ml of PI and 1 μg / ml of CFW for 5 min at RT. Finally, the coverslips were washed twice more with MOPS buffer, mounted and analyzed immediately by fluorescence microscopy using a Nikon Ni-U upright microscope equipped with TRITC and DAPI filters. Images were acquired using Nikon Elements software package.

Quantitation of viability by CFDA

Viability in the presence of caspofungin was analyzed using 5,(6)-Carboxyfluorescein Diacetate (CFDA) staining, as previously described [23]. Conidia (8x104) were inoculated into 4 ml of GMM broth with or without 0.5 μg / ml of caspofungin and poured onto sterile coverslips in 35mm petri dishes. Cultures were then incubated at 37°C to allow conidia to germinate and adhere to coverslips. At the indicated times, culture supernatants were discarded and coverslips were stained with a solution of 50 μg / ml CFDA (Invitrogen) in 0.1M MOPS buffer (pH 3) for 1 hour at 37°C and 250rpm. Coverslips were washed once in 0.1M MOPS buffer and mounted for microscopy. Fluorescence microscopy was performed on a Nikon NiU microscope equipped with a Nikon DS-Qi1Mc camera using GFP filter settings. The percentage of CFDA stained microcolonies was determined by manual counts and images were captured using Nikon Elements software (v4.0).

Animal studies

For survival studies, two different models of invasive pulmonary aspergillosis were employed, as previously described [56]. Each model utilized CF-1 female mice weighing approximately 25 g. For the corticosteroid model, mice were immunosuppressed with 40 mg / kg of triamcinolone acetonide (TA) (Kenalog, Bristol-Myers Squibb, Princeton, NJ, USA), given subcutaneously the day prior to the infection. For the chemotherapeutic model, mice were immune suppressed by the intraperitoneal administration of 150 mg / kg of cyclophosphamide, on days -3, +1, +4 and +7, in addition to the TA injection on day -1. On the day of the infection, mice were transiently anesthetized by the inhalation of isoflurane in an induction box (primary and secondary flow rate set at 0.5 liters / minute, 2.5% isoflurane) and inoculated by intranasal instillation with a suspension of 105 (initial survival studies) or 106 conidia (echinocandin therapy experiments) in 20 μl of saline solution. Survival and health status of the mice were monitored at least twice a day during a period of 15 days. Those mice showing severe signs of distress or disease were humanely euthanized by anoxia with CO2 followed by cervical dislocation. In order to prevent bacterial infections, mice were given a mixture of sulfamethoxazole and trimethoprim in the drinking water, starting 3 days before the inoculation.

To determine the in vivo susceptibility to echinocandins in selected mutants, mice were immunosuppressed and inoculated as described above and, in addition, were treated with 1 or 2 mg / kg of micafungin (Mycamine, Astellas Pharma Inc., Northbrook, IL, USA) intraperitoneally, once a day. Treatments started one day post-infection (day +1) and lasted 3 days (day +4). Mock groups were given saline alone. All echinocandin treatments were based on previously published studies [83]. Viable residual tissue burden in lungs of mice untreated or treated with micafungin was examined 6 hours (day 0) and 4 days (day +4) after infection. Mice were euthanized at the indicated time, lungs were aseptically harvested, sectioned into small pieces, and cultured on yeast peptone dextrose (YPD) agar for 48 hours at 37°C.

In addition to the survival studies, histopathology analyses were performed. Two mice per group were immunosuppressed and infected as described above and euthanized 4 days after the inoculation. Lungs were inflated by intratracheal perfusion with 10% buffered formalin and subsequently embedded in paraffin. Finally, multiple 5 μm sections from the superior, middle and inferior lobes were stained with Grocott’s methenamine silver for visualization of fungal elements.

Lung fungal burden and in vivo cytokine secretion

Lung fungal burden by quantitative PCR (qPCR) and measurement of in vivo cytokine secretion by ELISA were performed using slight modifications of previously described protocols [57,84]. Mice immune suppressed following the chemotherapeutic model described above were intranasally inoculated with 106 conidia. After 4 days of infection, mice were euthanized and lungs were harvested and homogenized in 1 ml of sterile PBS using the gentleMACS dissociator (Miltenyi Biotec). Approximately 700 μl of lung homogenate were lyophilized and processed for DNA extraction using the E.Z.N.A. Fungal DNA Mini Kit (Omega Bio-tek) according to manufacturer instructions. qPCR analyses were performed in technical duplicate for each sample, using the PrimeTime Gene Expression Master Mix and qPCR Probe Assays (Integrated DNA Technologies) containing the primers to amplify a region of the A. fumigatus 18S rRNA gene, as previously described [85]. For each sample, 500 ng of total DNA was used as template, and a standard curve containing 100, 10, 1, 0.1 and 0.01 ng of CEA10 genomic DNA was also included in the assay so that the amounts of A. fumigatus specific DNA could be determined. qPCR was conducted on a Bio-Rad CFX96 Real-Time PCR system running the Bio-Rad CFX Maestro 1.0 software (v4.0). Data are represented as nanograms of A. fumigatus specific DNA in 500 ng of total DNA.​

For analysis of cytokine secretion in the lungs, 300 μl of lung homogenate were mixed with 2x Protease Inhibitor Cocktail containing AEBSF, Aprotinin, Bestatin, E-64, Leupeptin and Pepstatin A (Sigma) and centrifuged at 14000 rpm for 10 minutes. Resulting supernatants were kept at -80°C until employed for further measurements using mouse TNFα and IL-1β ELISA kits (Invitrogen), according to manufacturer instructions. Total protein quantification was performed using Quick Start Bradford Protein Assay (Bio-Rad) and used for cytokine level normalization.

Analysis of cytokine release in THP-1 cells

WT (THP1-null), Nlrp3−/− (THP1-KO-NLRP3), and Asc−/− (THP1-KO-ASC) THP-1 cells (Invivogen) were utilized. Cytokine release from THP-1 cells was performed as previously described, with minor modifications [59,86]. Briefly, cells were cultured in RPMI-1640 medium containing 25 mM HEPES supplemented with 10% heat-inactivated Fetal Bovine Serum, 100 U/mL penicillin-streptomycin, and 100 μg/mL normocin as described previously. THP-1 cells were assessed for viability by exclusionary Trypan Blue staining and plated at a density of 105 cells/well in 96-well microtier plates using similar medium lacking normocin. Phorbol 12-myristate 13-acetate (PMA) was added at 100 nM final concentration and cells incubated for 24h to adopt a macrophage phenotype. Supernatants were discarded and replaced with 180 μl of fresh RPMI (without phenol red) and 20 μl of distilled water containing 106 A. fumigatus conidia (MOI 10:1) added. In some cases, the inflammasome inhibitor MCC950 (10 μM, Invivogen) was added to the THP-1 cells concomitantly with the conidia. THP-1 cells and conidia were co-cultured for 16h and supernatants were collected and analyzed by ELISA for IL-1β concentration following manufacturer instructions.

Supporting information

S1 Fig. Disruption of multiple protein kinase genes results in reduced colony growth and conidiation of A. fumigatus.

A) Quantitation of colony diameters for the wild type parent strain (CEA10) and disruption mutants displaying minimal, moderate or severe growth restriction on minimal media. 10,000 conidia from each strain were point-inoculated onto minimal media and cultured for 96 hrs at 37°C. Colony diameters form triplicate cultures for each strain were measured (mm) and averaged. Statistical comparisons were made by ANOVA and all comparisons generated a p ≤ 0.0371. Disruption mutants not shown generated colony diameters that were similar to CEA10. B) Quantitation of conidiation for the parent strain (CEA10) and multiple protein kinase gene disruption mutants. Conidia (2 x 104) from each strain were cultured as in (A). Colony area was calculated and conidia were harvested in 10 ml of sterile water before filtration and quantitation using a hemocytometer. Each strain was assayed in triplicate and data were averaged. Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons post hoc and all comparisons generated a p ≤ 0.0036. Disruption mutants not included here for colony diameter or conidiation analyses were not significantly different from the parental strain (CEA10).

(TIF)

S2 Fig. Gene deletion of sepH and gene reconstitution of the sepL disruption (sepL-1).

Schematics for deletion of sepH (A) and for complementation of the sepL-1 disruption mutant (C). Genetic manipulations were carried out using CRISPR/Cas9 gene editing (see Materials and Methods). For each locus targeted, the 20-nucleotide protospacer (black font) and the 3-nucleotide protospacer adjacent motif (PAM, underlined red font) are displayed. Each manipulation utilized Cas9-mediated double strand breaks generated 5’ and 3’ of the targeted gene. Repair templates (HygR = hygromycin resistance cassette; PhleoR = phleomycin resistance cassette) were PCR amplified from plasmids using primers that incorporated 40-basepair microhomology arms for targeting. Correct integration of repair templates was confirmed by PCR using primers P1 and P2 for sepH deletion (B) and primers P3 and P4 for sepL-1 complementation (D).

(TIF)

S3 Fig. Deletion and complementation of A. fumigatus genes AFUB_067160, encoding myosin light chain (mlcA), and AFUB_055850, encoding alpha-actinin (ainA).

Schematics for deletion (A and D) and complementation (B and E) of mlcA and ainA, respectively. Genetic manipulations were carried out using CRISPR/Cas9 gene editing (see Materials and Methods). For each locus targeted, the 20-nucleotide protospacer (black font) and the 3-nucleotide protospacer adjacent motif (PAM, underlined red font) are displayed. Each manipulation utilized Cas9-mediated double strand breaks generated 5’ and 3’ of the targeted gene. Repair templates (HygR = hygromycin resistance cassette) were PCR-amplified from plasmids using primers that incorporated 40-basepair microhomology arms for targeting. Correct integration of repair templates and gene complementations were confirmed by PCR using primers P5 and P6 for mlcA (A and B) and primers P7 and P8 for ainA (E and F).

(TIF)

S4 Fig. Gene disruption of A. fumigatus cell wall integrity kinases (mkk2 and mpkA) and the protein kinase A catalytic subunit (pkaC1) generates increased susceptibility to echinocandins.

Modified E-test assays for the mkk2-1, mpkA-1, and pkaC1-1 disruption mutants using minimal media (see Materials and Methods). Note the residual growth in the zone-of-clearance for both mkk2-1 and mpkA-1 mutants indicating lack of echinocandin cidal activity. Insets show representative, drug-free minimal media culture plates onto which a single agar plug from the zone-of-clearance for each assay was sub-cultured. Multiple agar plugs (n = 10), taken from within 1 cm of the E-test strip and between the 32 and 0.25 μg/ml markers, were sub-cultured in the same manner for each assay. CAS = caspofungin; MFG = micafungin.

(TIF)

S1 File

(XLSX)

Data Availability

All relevant data are within the manuscript and it Supporting Information files.

Funding Statement

This work was supported by NIH/NIAID (https://www.niaid.nih.gov/) awards R21AI142509 (JRF), R21AI139388 (JRF), R01AI158442 (JRF), R21AI127942 (BMP) and R01AI134796 (BMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan S-P, Meier-Kriesche H-U, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. Journal of Infection. 2012;65(5):453–64. doi: 10.1016/j.jinf.2012.08.003 [DOI] [PubMed] [Google Scholar]
  • 2.López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, et al. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study. Am J Transplant. 2016;16(11):3220–34. Epub 2016/10/28. doi: 10.1111/ajt.13837 . [DOI] [PubMed] [Google Scholar]
  • 3.Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, et al. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Int J Antimicrob Agents. 2017;49(2):218–23. Epub 2016/12/19. doi: 10.1016/j.ijantimicag.2016.10.019 . [DOI] [PubMed] [Google Scholar]
  • 4.Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. The Lancet. 2016;387(10020):760–9. doi: 10.1016/S0140-6736(15)01159-9 [DOI] [PubMed] [Google Scholar]
  • 5.Kim A, Nicolau DP, Kuti JL. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses. 2011;54(5):e301–12. Epub 2010/06/19. doi: 10.1111/j.1439-0507.2010.01903.x . [DOI] [PubMed] [Google Scholar]
  • 6.Latgé J-P, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clinical Microbiology Reviews. 2019;33(1):e00140–18. doi: 10.1128/CMR.00140-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009;26(4):223–7. Epub 2009/10/20. doi: 10.1016/j.riam.2009.06.003 . [DOI] [PubMed] [Google Scholar]
  • 8.Patterson TF, Thompson GR III, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;63(4):e1–e60. doi: 10.1093/cid/ciw326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348–59. Epub 2007/01/26. doi: 10.1056/NEJMoa061094 . [DOI] [PubMed] [Google Scholar]
  • 10.Pinney MF, Rosenberg AF, Hampp C, Schain D, Akindipe O, Baz M. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center. Pharmacotherapy. 2011;31(6):537–45. Epub 2011/09/20. doi: 10.1592/phco.31.6.537 . [DOI] [PubMed] [Google Scholar]
  • 11.Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease. New England Journal of Medicine. 2007;356(4):335–47. doi: 10.1056/NEJMoa061098 . [DOI] [PubMed] [Google Scholar]
  • 12.Burgel P-R, Baixench M-T, Amsellem M, Audureau E, Chapron J, Kanaan R, et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrobial agents and chemotherapy. 2012;56(2):869–74. Epub 2011/11/28. doi: 10.1128/AAC.05077-11 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hodiamont CJ, Dolman KM, Ten Berge IJ, Melchers WJ, Verweij PE, Pajkrt D. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol. 2009;47(2):217–20. Epub 2008/12/23. doi: 10.1080/13693780802545600 . [DOI] [PubMed] [Google Scholar]
  • 14.van Paassen J, Russcher A, In ’t Veld-van Wingerden AW, Verweij PE, Kuijper EJ. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. Euro Surveill. 2016;21(30). Epub 2016/08/20. doi: 10.2807/1560-7917.ES.2016.21.30.30300. [DOI] [PubMed] [Google Scholar]
  • 15.Wiederhold NP, Gil VG, Gutierrez F, Lindner JR, Albataineh MT, McCarthy DI, et al. First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States. Journal of Clinical Microbiology. 2016;54(1):168–71. doi: 10.1128/JCM.02478-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clin Infect Dis. 2016;62(3):362–8. Epub 2015/10/22. doi: 10.1093/cid/civ885 ; PubMed Central PMCID: PMC4706635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA. Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene. Antimicrobial Agents and Chemotherapy. 2011;55(9):4465–8. doi: 10.1128/AAC.00185-11 PMC3165364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. Journal of Antimicrobial Chemotherapy. 2010;65(10):2116–8. doi: 10.1093/jac/dkq279 [DOI] [PubMed] [Google Scholar]
  • 19.Susan JH, Dasa C, Michael JA, Ahmed A, Matthew CF, Alessandro CP, et al. Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure. Emerging Infectious Disease journal. 2009;15(7):1068. doi: 10.3201/eid1507.090043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Walker TA, Lockhart SR, Beekmann SE, Polgreen PM, Santibanez S, Mody RK, et al. Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States. Emerg Infect Dis. 2018;24(1):111–3. Epub 2017/12/21. doi: 10.3201/eid2401.170971 ; PubMed Central PMCID: PMC5749442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aruanno M, Glampedakis E, Lamoth F. Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside. Antimicrob Agents Chemother. 2019;63(8). Epub 2019/05/30. doi: 10.1128/aac.00399-19; PubMed Central PMCID: PMC6658788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Beauvais A, Bruneau JM, Mol PC, Buitrago MJ, Legrand R, Latgé JP. Glucan synthase complex of Aspergillus fumigatus. Journal of bacteriology. 2001;183(7):2273–9. doi: 10.1128/JB.183.7.2273-2279.2001 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, et al. The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro. Antimicrob Agents Chemother. 2002;46(9):3001–12. doi: 10.1128/AAC.46.9.3001-3012.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, et al. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrobial agents and chemotherapy. 2002;46(9):3001–12. doi: 10.1128/AAC.46.9.3001-3012.2002 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wagener J, Loiko V. Recent Insights into the Paradoxical Effect of Echinocandins. J Fungi (Basel). 2017;4(1):5. doi: 10.3390/jof4010005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lionakis MS, Lewis RE, Kontoyiannis DP. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clin Infect Dis. 2018;67(10):1621–30. Epub 2018/06/04. doi: 10.1093/cid/ciy473 ; PubMed Central PMCID: PMC6206100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gomes MZ, Jiang Y, Mulanovich VE, Lewis RE, Kontoyiannis DP. Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia. Antimicrob Agents Chemother. 2014;58(5):2775–80. Epub 2014/03/05. doi: 10.1128/AAC.01527-13 ; PubMed Central PMCID: PMC3993271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mattos EC, Palmisano G, Goldman GH. Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin. mSphere. 2020;5(3):e00365–20. doi: 10.1128/mSphere.00365-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mattos EC, Silva LP, Valero C, de Castro PA, dos Reis TF, Ribeiro LFC, et al. The Aspergillus fumigatus Phosphoproteome Reveals Roles of High-Osmolarity Glycerol Mitogen-Activated Protein Kinases in Promoting Cell Wall Damage and Caspofungin Tolerance. mBio. 2020;11(1):e02962–19. doi: 10.1128/mBio.02962-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chelius C, Huso W, Reese S, Doan A, Lincoln S, Lawson K, et al. Dynamic Transcriptomic and Phosphoproteomic Analysis During Cell Wall Stress in Aspergillus nidulans. Molecular & Cellular Proteomics. 2020;19(8):1310–29. doi: 10.1074/mcp.RA119.001769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Silva LP, Frawley D, Assis LJd, Tierney C, Fleming AB, Bayram O, et al. Putative Membrane Receptors Contribute to Activation and Efficient Signaling of Mitogen-Activated Protein Kinase Cascades during Adaptation of Aspergillus fumigatus to Different Stressors and Carbon Sources. mSphere. 2020;5(5):e00818–20. doi: 10.1128/mSphere.00818-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Manfiolli AO, Mattos EC, de Assis LJ, Silva LP, Ulaş M, Brown NA, et al. Aspergillus fumigatus High Osmolarity Glycerol Mitogen Activated Protein Kinases SakA and MpkC Physically Interact During Osmotic and Cell Wall Stresses. Frontiers in Microbiology. 2019;10(918). doi: 10.3389/fmicb.2019.00918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Juvvadi PR, Cole DC, Falloon K, Waitt G, Soderblom EJ, Moseley MA, et al. Kin1 kinase localizes at the hyphal septum and is dephosphorylated by calcineurin but is dispensable for septation and virulence in the human pathogen Aspergillus fumigatus. Biochemical and Biophysical Research Communications. 2018;505(3):740–6. doi: 10.1016/j.bbrc.2018.09.186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Altwasser R, Baldin C, Weber J, Guthke R, Kniemeyer O, Brakhage AA, et al. Network Modeling Reveals Cross Talk of MAP Kinases during Adaptation to Caspofungin Stress in Aspergillus fumigatus. PLOS ONE. 2015;10(9):e0136932. doi: 10.1371/journal.pone.0136932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Valiante V, Jain R, Heinekamp T, Brakhage AA. The MpkA MAP kinase module regulates cell wall integrity signaling and pyomelanin formation in Aspergillus fumigatus. Fungal Genetics and Biology. 2009;46(12):909–18. doi: 10.1016/j.fgb.2009.08.005 [DOI] [PubMed] [Google Scholar]
  • 36.Steinbach WJ, Cramer RA Jr., Perfect BZ, Henn C, Nielsen K, Heitman J, et al. Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother. 2007;51(8):2979–81. doi: 10.1128/AAC.01394-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Simanis V. The mitotic exit and septation initiation networks. Journal of Cell Science. 2003;116(21):4261–2. doi: 10.1242/jcs.00777 [DOI] [PubMed] [Google Scholar]
  • 38.Bardin AJ, Amon A. MEN and SIN: what’s the difference? Nature Reviews Molecular Cell Biology. 2001;2(11):815–26. doi: 10.1038/35099020 [DOI] [PubMed] [Google Scholar]
  • 39.De Souza CP, Hashmi SB, Osmani AH, Andrews P, Ringelberg CS, Dunlap JC, et al. Functional Analysis of the Aspergillus nidulans Kinome. PLOS ONE. 2013;8(3):e58008. doi: 10.1371/journal.pone.0058008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Al Abdallah Q, Ge W, Fortwendel JR. A Simple and Universal System for Gene Manipulation in Aspergillus fumigatus In Vitro-Assembled Cas9-Guide RNA Ribonucleoproteins Coupled with Microhomology Repair Templates. mSphere. 2017;2(6). doi: 10.1128/mSphere.00446-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Al Abdallah Q, Souza ACO, Martin-Vicente A, Ge W, Fortwendel JR. Whole-genome sequencing reveals highly specific gene targeting by in vitro assembled Cas9-ribonucleoprotein complexes in Aspergillus fumigatus. Fungal Biol Biotechnol. 2018;5:11. Epub 2018/07/12. doi: 10.1186/s40694-018-0057-2; PubMed Central PMCID: PMC5987418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fuller KK, Richie DL, Feng X, Krishnan K, Stephens TJ, Wikenheiser-Brokamp KA, et al. Divergent Protein Kinase A isoforms co-ordinately regulate conidial germination, carbohydrate metabolism and virulence in Aspergillus fumigatus. Molecular Microbiology. 2011;79(4):1045–62. doi: 10.1111/j.1365-2958.2010.07509.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Vargas-Muñiz JM, Renshaw H, Richards AD, Waitt G, Soderblom EJ, Moseley MA, et al. Dephosphorylation of the Core Septin, AspB, in a Protein Phosphatase 2A-Dependent Manner Impacts Its Localization and Function in the Fungal Pathogen Aspergillus fumigatus. Frontiers in Microbiology. 2016;7(997). doi: 10.3389/fmicb.2016.00997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Du C, Sarfati J, Latge JP, Calderone R. The role of the sakA (Hog1) and tcsB (sln1) genes in the oxidant adaptation of Aspergillus fumigatus. Medical Mycology. 2006;44(3):211–8. doi: 10.1080/13693780500338886 [DOI] [PubMed] [Google Scholar]
  • 45.Sasse C, Bignell EM, Hasenberg M, Haynes K, Gunzer M, Braus GH, et al. Basal expression of the Aspergillus fumigatus transcriptional activator CpcA is sufficient to support pulmonary aspergillosis. Fungal Genetics and Biology. 2008;45(5):693–704. doi: 10.1016/j.fgb.2007.12.008 [DOI] [PubMed] [Google Scholar]
  • 46.Long N, Zeng L, Qiao S, Li L, Zhong G. Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse Regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates, and Efflux Pumps to Biofilm. Antimicrobial Agents and Chemotherapy. 2018;62(3):e01978–17. doi: 10.1128/AAC.01978-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Frawley D, Stroe MC, Oakley BR, Heinekamp T, Straßburger M, Fleming AB, et al. The Pheromone Module SteC-MkkB-MpkB-SteD-HamE Regulates Development, Stress Responses and Secondary Metabolism in Aspergillus fumigatus. Frontiers in Microbiology. 2020;11(811). doi: 10.3389/fmicb.2020.00811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ram AFJ, Klis FM. Identification of fungal cell wall mutants using susceptibility assays based on Calcofluor white and Congo red. Nature Protocols. 2006;1(5):2253–6. doi: 10.1038/nprot.2006.397 [DOI] [PubMed] [Google Scholar]
  • 49.CLSI. Reference Method for broth microdilution antifungal susceptibility testing of filamentous fungi. 3rd. ed. CLSI standard M38 Wayne, PA: Clinical and Laboratory Standards Institute. 2017. [Google Scholar]
  • 50.Shwab EK, Juvvadi PR, Waitt G, Soderblom EJ, Moseley MA, Nicely NI, et al. A Novel Phosphoregulatory Switch Controls the Activity and Function of the Major Catalytic Subunit of Protein Kinase A in Aspergillus fumigatus. mBio. 2017;8(1):e02319–16. doi: 10.1128/mBio.02319-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Dichtl K, Helmschrott C, Dirr F, Wagener J. Deciphering cell wall integrity signalling in Aspergillus fumigatus: identification and functional characterization of cell wall stress sensors and relevant Rho GTPases. Mol Microbiol. 2012;83(3):506–19. Epub 2012/01/10. doi: 10.1111/j.1365-2958.2011.07946.x . [DOI] [PubMed] [Google Scholar]
  • 52.Heilig Y, Schmitt K, Seiler S. Phospho-Regulation of the Neurospora crassa Septation Initiation Network. PLOS ONE. 2013;8(10):e79464. doi: 10.1371/journal.pone.0079464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kim J-M, Zeng CJT, Nayak T, Shao R, Huang A-C, Oakley BR, et al. Timely Septation Requires SNAD-dependent Spindle Pole Body Localization of the Septation Initiation Network Components in the Filamentous Fungus Aspergillus nidulans. Molecular Biology of the Cell. 2009;20(12):2874–84. doi: 10.1091/mbc.e08-12-1177 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Dichtl K, Samantaray S, Aimanianda V, Zhu Z, Prevost M-C, Latgé JP, et al. Aspergillus fumigatus devoid of cell wall B-1,3-glucan is viable, massively shed galactomannan and is killed by septum formation inhibitors. Mol Microbiol. 2014;95(3):458–71. doi: 10.1111/mmi.12877 [DOI] [PubMed] [Google Scholar]
  • 55.Ingham CJ, Schneeberger PM. Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities. PLOS ONE. 2012;7(4):e35478. doi: 10.1371/journal.pone.0035478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Souza ACO, Al Abdallah Q, DeJarnette K, Martin-Vicente A, Nywening AV, DeJarnette C, et al. Differential requirements of protein geranylgeranylation for the virulence of human pathogenic fungi. Virulence. 2019;10(1):511–26. doi: 10.1080/21505594.2019.1620063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Norton TS, Al Abdallah Q, Hill AM, Lovingood RV, Fortwendel JR. The Aspergillus fumigatus farnesyltransferase β-subunit, RamA, mediates growth, virulence, and antifungal susceptibility. Virulence. 2017:1–16. doi: 10.1080/21505594.2017.1328343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Briard B, Fontaine T, Samir P, Place DE, Muszkieta L, Malireddi RKS, et al. Galactosaminogalactan activates the inflammasome to provide host protection. Nature. 2020;588(7839):688–92. doi: 10.1038/s41586-020-2996-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Saïd-Sadier N, Padilla E, Langsley G, Ojcius DM. Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase. PLOS ONE. 2010;5(4):e10008. doi: 10.1371/journal.pone.0010008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Malik A, Kanneganti T-D. Inflammasome activation and assembly at a glance. Journal of Cell Science. 2017;130(23):3955–63. doi: 10.1242/jcs.207365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wang J, Hu H, Wang S, Shi J, Chen S, Wei H, et al. The important role of actinin-like protein (AcnA) in cytokinesis and apical dominance of hyphal cells in Aspergillus nidulans. Microbiology. 2009;155(8):2714–25. 10.1099/mic.0.029215-0. [DOI] [PubMed] [Google Scholar]
  • 62.Li Y, Christensen JR, Homa KE, Hocky GM, Fok A, Sees JA, et al. The F-actin bundler α-actinin Ain1 is tailored for ring assembly and constriction during cytokinesis in fission yeast. Molecular Biology of the Cell. 2016;27(11):1821–33. doi: 10.1091/mbc.E16-01-0010 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Meitinger F, Palani S. Actomyosin ring driven cytokinesis in budding yeast. Seminars in Cell & Developmental Biology. 2016;53:19–27. 10.1016/j.semcdb.2016.01.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Stevens RC, Davis TN. Mlc1p is a light chain for the unconventional myosin Myo2p in Saccharomyces cerevisiae. J Cell Biol. 1998;142(3):711–22. doi: 10.1083/jcb.142.3.711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.McCollum D, Balasubramanian MK, Pelcher LE, Hemmingsen SM, Gould KL. Schizosaccharomyces pombe cdc4+ gene encodes a novel EF-hand protein essential for cytokinesis. Journal of Cell Biology. 1995;130(3):651–60. doi: 10.1083/jcb.130.3.651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Krapp A, Simanis V. An overview of the fission yeast septation initiation network (SIN). Biochem Soc Trans. 2008;36(Pt 3):411–5. Epub 2008/05/17. doi: 10.1042/BST0360411 . [DOI] [PubMed] [Google Scholar]
  • 67.Samantaray S, Neubauer M, Helmschrott C, Wagener J. Role of the guanine nucleotide exchange factor Rom2 in cell wall integrity maintenance of Aspergillus fumigatus. Eukaryotic cell. 2013;12(2):288–98. Epub 2012/12/21. doi: 10.1128/EC.00246-12 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Si H, Justa-Schuch D, Seiler S, Harris SD. Regulation of septum formation by the Bud3-Rho4 GTPase module in Aspergillus nidulans. Genetics. 2010;185(1):165–76. Epub 2010/02/22. doi: 10.1534/genetics.110.114165 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Laporte D, Zhao R, Wu J-Q. Mechanisms of contractile-ring assembly in fission yeast and beyond. Seminars in Cell & Developmental Biology. 2010;21(9):892–8. doi: 10.1016/j.semcdb.2010.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Moreno-Velásquez SD, Seidel C, Juvvadi PR, Steinbach WJ, Read ND. Caspofungin-Mediated Growth Inhibition and Paradoxical Growth in Aspergillus fumigatus Involve Fungicidal Hyphal Tip Lysis Coupled with Regenerative Intrahyphal Growth and Dynamic Changes in β-1,3-Glucan Synthase Localization. Antimicrobial Agents and Chemotherapy. 2017;61(10):e00710–17. doi: 10.1128/AAC.00710-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Markham P. Occlusions of septal pores in filamentous fungi. Mycological Research. 1994;98(10):1089–106. 10.1016/S0953-7562(09)80195-0. [DOI] [Google Scholar]
  • 72.Steinberg G, Harmer NJ, Schuster M, Kilaru S. Woronin body-based sealing of septal pores. Fungal Genetics and Biology. 2017;109:53–5. doi: 10.1016/j.fgb.2017.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Munro CA, Winter K, Buchan A, Henry K, Becker JM, Brown AJP, et al. Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Molecular Microbiology. 2001;39(5):1414–26. doi: 10.1046/j.1365-2958.2001.02347.x [DOI] [PubMed] [Google Scholar]
  • 74.Walker LA, Lenardon MD, Preechasuth K, Munro CA, Gow NAR. Cell wall stress induces alternative fungal cytokinesis and septation strategies. Journal of Cell Science. 2013;126(12):2668–77. doi: 10.1242/jcs.118885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Hohl TM. Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities. Curr Opin Infect Dis. 2017;30(4):364–71. doi: 10.1097/QCO.0000000000000381 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Freitag J, Lanver D, Böhmer C, Schink KO, Bölker M, Sandrock B. Septation of Infectious Hyphae Is Critical for Appressoria Formation and Virulence in the Smut Fungus Ustilago Maydis. PLOS Pathogens. 2011;7(5):e1002044. doi: 10.1371/journal.ppat.1002044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Fukuda S, Yamamoto R, Yanagisawa N, Takaya N, Sato Y, Riquelme M, et al. Trade-off between Plasticity and Velocity in Mycelial Growth. mBio. 2021;12(2):e03196–20. doi: 10.1128/mBio.03196-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Fortwendel JR, Zhao W, Bhabhra R, Park S, Perlin DS, Askew DS, et al. A Fungus-Specific Ras Homolog Contributes to the Hyphal Growth and Virulence of Aspergillus fumigatus. Eukaryotic Cell. 2005;4(12):1982–9. doi: 10.1128/EC.4.12.1982-1989.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.He Z-M, Price MS, Obrian GR, Georgianna DR, Payne GA. Improved protocols for functional analysis in the pathogenic fungus Aspergillus flavus. BMC Microbiology. 2007;7(1):104. doi: 10.1186/1471-2180-7-104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Fortwendel JR, Juvvadi PR, Rogg LE, Asfaw YG, Burns KA, Randell SH, et al. Plasma membrane localization is required for RasA-mediated polarized morphogenesis and virulence of Aspergillus fumigatus. Eukaryotic Cell. 2012;11(8):966–77. doi: 10.1128/EC.00091-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Espinel-Ingroff A, Rezusta A. E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. Journal of Clinical Microbiology. 2002;40(6):2101–7. doi: 10.1128/JCM.40.6.2101-2107.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Fortwendel JR, Fuller KK, Stephens TJ, Bacon WC, Askew DS, Rhodes JC. Aspergillus fumigatus RasA regulates asexual development and cell wall integrity. Euk Cell. 2008;7(9):1530–9. doi: 10.1128/EC.00080-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Lewis RE, Albert ND, Kontoyiannis DP. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy. 2008;61(5):1140–4. doi: 10.1093/jac/dkn069 [DOI] [PubMed] [Google Scholar]
  • 84.Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM, Watschke CP, et al. IL-1α Signaling Is Critical for Leukocyte Recruitment after Pulmonary Aspergillus fumigatus Challenge. PLOS Pathogens. 2015;11(1):e1004625. doi: 10.1371/journal.ppat.1004625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Bowman JC, Abruzzo GK, Anderson JW, Flattery AM, Gill CJ, Pikounis VB, et al. Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate. Antimicrobial Agents and Chemotherapy. 2001;45(12):3474–81. doi: 10.1128/AAC.45.12.3474-3481.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Willems HME, Lowes DJ, Barker KS, Palmer GE, Peters BM. Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology. Infection and Immunity. 2018;86(12):e00527–18. doi: 10.1128/IAI.00527-18 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Alex Andrianopoulos, Robert A Cramer

28 Jun 2021

Dear Dr Fortwendel,

Thank you very much for submitting your manuscript "Loss of Septation Initiation Network (SIN) kinases blocks tissue invasion and unlocks echinocandin cidal activity against Aspergillus fumigatus" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Specifically, all three reviewers appreciated the novelty and impact of the work on our understanding of kinases involved in A. fumigatus pathogenesis and interactions with the echinocandins. While several interesting and informative experiments around the specific impact of the SIN kinase mutants on the phenotypes observed are suggested by all 3 reviewers, I will leave it to you to decide whether you'd like to address these experimentally or through a softening of the conclusions drawn based on the current data. The manuscript contains significant new data and a new resource for the community. It is clear that the excellent reviewer suggestions will strengthen our mechanistic understanding of the phenotypes observed, but (at your discretion) they may be beyond the scope of the current study given the nature of the suggested experiments, particularly those related to the cell wall and kinase molecular function.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Robert A. Cramer, PhD

Associate Editor

PLOS Pathogens

Alex Andrianopoulos

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: This ms uses CRISPR/Cas9-mediated gene targeting to generate a library of protein kinase disruption mutants in A. fumigatus. The library was then challenged with cell wall stress agents (CR, CFW and caspofungin) in order to identify those kinases that participate in adaptive responses to loss of cell wall integrity. Several mutants were identified that confirmed what is already known in the literature, nicely demonstrating the validity of this mutation/screening strategy. The focus of the subsequent analysis was on three kinase genes, comprising a tripartite kinase cascade known as the septation initiation network (SIN). The data reveal that deletion of any of these three genes abrogates hyphal septation and increases susceptibility to cell wall stress. Importantly, this correlated with extensive hyphal damage in response to treatment with echinocandins, as well as a striking loss of invasive growth potential in two immunologically distinct mouse models of infection. By analyzing other non-kinase regulators of septation the study provides evidence that these phenotypes are a likely consequence of septation deficiency rather than SIN-kinase dependent activity. The study also demonstrates that echinocandin therapy is effective at eliminating residual fungal burden in mice infected with septation-deficient mutants, providing proof of principle that septation inhibitors would be effective in combination therapy with the echinocandin class.

The manuscript was very well written, the data are compelling, and the conclusions are supported by the findings. The major strength of the paper is that the study provides new evidence that A. fumigatus relies on septation for invasive growth and that the efficacy of echinocandin therapy could be amplified by septation inhibitors.

Reviewer #2: This impressive and interesting study describes the authors’ efforts to characterize protein kinases of A. fumigatus on a comprehensive scale and to scrutinize the role of a selected set of kinases in the context of antifungal resistance adaptation. More specifically, 118 disruption mutants in genes encoding conserved protein kinases were generated and comprehensively screened for growth, fitness, and, mostly relevant, minimum effective concentrations of the fungal cell wall synthesis inhibitors of the echinocandin class. Emerging from these activities, two kinases presumed to serve as core components of the SIN cascade were characterized in depth to reveal their role in septation and virulence. In essence, the importance of septation within the fungal fungal hypha to counter cell wall stress and to support invasive growth within a susceptible host could be demonstrated.

Reviewer #3: This is a well written and interesting study that presents an impressive amount of work demonstrating the importance of Aspergillus fumigatus SIN kinases in virulence as well as "resistance" to the cidal effects of echinocandins. The experiments are well designed, the data is convincing and the paper is well written an thoughtful.

My only real comment is understanding the link between virulence/resistand and septation per se vs septation-associated biological processes. While I would like to believe that septation is what saves Aspergillus fumigatus from candins, and the data presented is certainly is compatible with this, we know that C. albicans can form septae, yet is highly susceptible to the cidal activity of these agents - so it seems that septae are not a guaranteed way to resist these agents. The obvious question that remains unanswered is - what are the effects of these deletions on the composition of the cell wall other than affecting septation? It looks to me like the sepH mutant has increased CFW staining, and the altered sensitivity to other cell wall agents suggests there are fundamental changes to the cell wall for these mutants.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: I realize that the focus is on echinocandins, but I think the echinocandin results really beg the question about other antifungal classes. Is there any hypersensitivity to nikkomycin or triazoles?

Reviewer #2: Given the plethora of novel and relevant data, relevance of this manuscript is clearly seen by this reviewer. Two interlinked scientific parts are presented, the rather shallow characterization of more than 100 protein kinase mutants that had been generated by an innovative semi-high-throughput approach, to be followed by extensive phenotyping of putative SIN kinase disruptants and regulators of hyphal septation. To fully exploit the range of insights that might be gained from the presented mutants and their phenotypes, some further lines of research could be followed and experimental tasks executed, such as biochemical studies on the presumed kinase targets and their phosphorylation or exploring the postulated positive effect of suited kinase inhibitors or septum formation inhibitors on echinocandin activity (static vs. cidal) and therapy. Yet, the most interesting question arises from the striking phenotype of avirulence that is displayed by the SIN kinase mutants upon pulmonary infection of susceptible mice: Presuming that this results from hampered tissue invasion, one wonders about the outcome in a systemic infection setting…

Reviewer #3: I would suggest doing an analysis of the cell wall glycan composition of these mutants (with and without echinocandins), at least to confirm if the standard cell wall integrity responses are compromised, and if there are fundamental changes in glycans that could contribute to the observations in the paper. If this is not done, I would suggest a careful rewrite of the discussion to emphasize that while clearly the SIN kinases are required for all the observed phenotypes (and dramatically so!), the current experiments do not distinguish between septation per se, and other SIN kinase-dependent process, as potential mechanisms underlying the findings.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: It is interesting that similar mutants in a plant pathogen reduce turgor pressure necessary for appressoria, raising the possibility that the lack of invasiveness is a related problem. Will the mutants grow on explants of lung tissue tissue on plates similar to how they behave on minimal medium? If they can’t invade the substrate, perhaps not. This could get complicated, so perhaps experiments along these lines would be best left to a follow-up study that delves into the invasive properties of the hyphae.

Are the mutants temperature sensitive? This is not a major issue since the focus of the ms is on pathogenesis and hence 37oC is the most relevant. However, I would be curious to see it mentioned in the discussion if the results are already available.

Line 67 – is limited by patient toxicity and threatened by resistance

Reviewer #2: Besides these rather general points, a couple of other, more specific ones exist that might be addressed before considering this fine manuscript for publication in PLoS Pathogens; in detail, these are as follows:

Significant parts of the Introduction are spent on describing results (e.g., l. 99-106 or l. 121-131). Maybe providing more context with respect to invasive(!) aspergillosis and knowledge about virulence determinants thereof might be illustrative without giving away too many findings. In the Results section, it is puzzling why the disruption library was established in the CEA10 wild-type isolate after identifying kinase-encoding orthologues in the genome sequences of A1163 and Af293 (l. 137-145) – please clarify for the readers that are not familiar with A. fumigatus laboratory isolate lineages. What might be the reason for the unexpected observation that several protein kinase mutants display a mild growth reduction that has not, with the exception of bck1, been described for any of the corresponding A. fumigatus mutants before (l. 185-193)? What is the actual mode of action for the cell wall stressors Calcofluor White and Congo Red (l. 208/9)? The notion that some of the library strains might not be altered in the respective gene function is puzzling (l. 219/202) – to what extent was this checked for the bck1 gene that gave rise to this suspicion albeit displaying a growth phenotype? Hyphal damage of SIN kinase mutants in the presence of micafungin is demonstrated by PI permeability assays (l. 319-330), which could be further supported by leakage experiments using strains that express fluorescent proteins. Description of the virulence phenotypes of SIN kinase mutants (l. 349-352) is somehow unclear. When confirming dependency of IL-1beta secretion on NLRP3 inflammasome activity (l. 380-385), citing one of the most recent literature on this rather distractive issue (e. g., PMID: 33268895) might be convenient. The Discussion’s reasoning that viable fungal elements are especially problematic for neutropenic patients (l. 556-557) is somehow awkward. When speculating on the lack of turgor pressure in the tip compartment being the underlying mechanisms for the observed virulence and tissue invasion phenotypes, recent insights deduced from microfluidic experimentations (PMID: 33727355) could be incorporated.

Reviewer #3: none

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Decision Letter 1

Alex Andrianopoulos, Robert A Cramer

16 Jul 2021

Dear Dr Fortwendel,

We are pleased to inform you that your manuscript 'Loss of Septation Initiation Network (SIN) kinases blocks tissue invasion and unlocks echinocandin cidal activity against Aspergillus fumigatus' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Robert A. Cramer, PhD

Associate Editor

PLOS Pathogens

Alex Andrianopoulos

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Acceptance letter

Alex Andrianopoulos, Robert A Cramer

4 Aug 2021

Dear Dr Fortwendel,

We are delighted to inform you that your manuscript, "Loss of Septation Initiation Network (SIN) kinases blocks tissue invasion and unlocks echinocandin cidal activity against Aspergillus fumigatus," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Disruption of multiple protein kinase genes results in reduced colony growth and conidiation of A. fumigatus.

    A) Quantitation of colony diameters for the wild type parent strain (CEA10) and disruption mutants displaying minimal, moderate or severe growth restriction on minimal media. 10,000 conidia from each strain were point-inoculated onto minimal media and cultured for 96 hrs at 37°C. Colony diameters form triplicate cultures for each strain were measured (mm) and averaged. Statistical comparisons were made by ANOVA and all comparisons generated a p ≤ 0.0371. Disruption mutants not shown generated colony diameters that were similar to CEA10. B) Quantitation of conidiation for the parent strain (CEA10) and multiple protein kinase gene disruption mutants. Conidia (2 x 104) from each strain were cultured as in (A). Colony area was calculated and conidia were harvested in 10 ml of sterile water before filtration and quantitation using a hemocytometer. Each strain was assayed in triplicate and data were averaged. Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons post hoc and all comparisons generated a p ≤ 0.0036. Disruption mutants not included here for colony diameter or conidiation analyses were not significantly different from the parental strain (CEA10).

    (TIF)

    S2 Fig. Gene deletion of sepH and gene reconstitution of the sepL disruption (sepL-1).

    Schematics for deletion of sepH (A) and for complementation of the sepL-1 disruption mutant (C). Genetic manipulations were carried out using CRISPR/Cas9 gene editing (see Materials and Methods). For each locus targeted, the 20-nucleotide protospacer (black font) and the 3-nucleotide protospacer adjacent motif (PAM, underlined red font) are displayed. Each manipulation utilized Cas9-mediated double strand breaks generated 5’ and 3’ of the targeted gene. Repair templates (HygR = hygromycin resistance cassette; PhleoR = phleomycin resistance cassette) were PCR amplified from plasmids using primers that incorporated 40-basepair microhomology arms for targeting. Correct integration of repair templates was confirmed by PCR using primers P1 and P2 for sepH deletion (B) and primers P3 and P4 for sepL-1 complementation (D).

    (TIF)

    S3 Fig. Deletion and complementation of A. fumigatus genes AFUB_067160, encoding myosin light chain (mlcA), and AFUB_055850, encoding alpha-actinin (ainA).

    Schematics for deletion (A and D) and complementation (B and E) of mlcA and ainA, respectively. Genetic manipulations were carried out using CRISPR/Cas9 gene editing (see Materials and Methods). For each locus targeted, the 20-nucleotide protospacer (black font) and the 3-nucleotide protospacer adjacent motif (PAM, underlined red font) are displayed. Each manipulation utilized Cas9-mediated double strand breaks generated 5’ and 3’ of the targeted gene. Repair templates (HygR = hygromycin resistance cassette) were PCR-amplified from plasmids using primers that incorporated 40-basepair microhomology arms for targeting. Correct integration of repair templates and gene complementations were confirmed by PCR using primers P5 and P6 for mlcA (A and B) and primers P7 and P8 for ainA (E and F).

    (TIF)

    S4 Fig. Gene disruption of A. fumigatus cell wall integrity kinases (mkk2 and mpkA) and the protein kinase A catalytic subunit (pkaC1) generates increased susceptibility to echinocandins.

    Modified E-test assays for the mkk2-1, mpkA-1, and pkaC1-1 disruption mutants using minimal media (see Materials and Methods). Note the residual growth in the zone-of-clearance for both mkk2-1 and mpkA-1 mutants indicating lack of echinocandin cidal activity. Insets show representative, drug-free minimal media culture plates onto which a single agar plug from the zone-of-clearance for each assay was sub-cultured. Multiple agar plugs (n = 10), taken from within 1 cm of the E-test strip and between the 32 and 0.25 μg/ml markers, were sub-cultured in the same manner for each assay. CAS = caspofungin; MFG = micafungin.

    (TIF)

    S1 File

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and it Supporting Information files.


    Articles from PLoS Pathogens are provided here courtesy of PLOS

    RESOURCES